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Abstract: The prenyl fragment represents the most basic building block in terpenoids, a 
family of numerous and structurally diverse natural products that are known to possess 
interesting biological properties. In contrast, multifluorinated arenes are an important 
class of compounds that have found great utility in agricultural, material, and 
pharmaceutical industries. Fluorine substitution has been shown to impart a number of 
positive attributes including resistance to metabolic degradation, enhanced lipophilicity, 
and improved binding and passive diffusion of compounds across membranes. While 
allylation chemistry is well developed, effective prenylation strategies have been less 
forthcoming. Herein, we describe the defluoroprenylation via photocatalysis, a powerful 
method that provides access to “hybrid molecules” containing both the functionality of a 
prenyl group and fluorinated arenes. This approach involves direct prenyl group transfer 
under very mild conditions, displays excellent functional group tolerance, and relatively 
short reaction times (<4 h), which is the fastest photocatalytic C–F functionalization 
developed to date. Additionally, the strategy can be further extended to include allyl and 
geranyl (10 carbon fragment) transfer. Another prominent finding is a reagent dependent 
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The prenyl group is the most basic building block of terpenoid natural products and thus 
possesses interesting biological properties.1 Terpenes are a large and varied class of organic 
compounds that are known to possess a variety of impressive biological properties.2 These 
diverse bioactive structures have been widely utilized in delivering pharmacological properties,3 
used as natural flavoring compounds in food industry4 and are the primary constituents of 
essential oils of a variety of medicinal plants and flowers.5  Some of the common terpenes (Figure 
1.1) include myrcene (known for its highly sedative effects),6 limonene (common in citrus and a 
known anti-depressant),6-7 terpinolene (with woody aroma, slight sedative, antioxidant, anticancer 
and antibacterial),8 beta-caryophyllene (gastroprotective and a strong anti-inflammatory with a 
woody, peppery taste),9 α-pinene (energetic and therapeutic common in pine needles),10 humulene 
(main constituent of hops, strong anti-inflammatory agent and hunger-suppressant).11 All 
terpenoids are synthesized from the same five-carbon building blocks (dimethylallyl 
pyrophosphate and isopentenyl pyrophosphate) but their structures and functions can be 




Figure 1.1: Some common examples of Terpenes.  
over the last century, namely steroids, artemisinins, tocopherols, taxanes, ingenanes and 
cannabinoids. Some of the renowned terpene-based drugs include the anticancer drug Taxol 
(Paclitaxel) and the antimalarial drug Artimesinin (a sesquiterpene lactone).13 Parthenolide, 
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another sesquiterpene lactone, exhibits exceptional anticancer and anti-inflammatory properties, 
that makes it a prominent drug candidate in development studies. Over the last 40 years, a large 
family of marine terpenes have also received attention for thier promising potential in medical 
applications. For instance, sarcodictyin A and eleutherobin from the Australian soft coral 
eleutherobia sp. and the stoloniferan coral sarcodictyon roseum respectively, are known to 
exhibit potent antitumor activity against a variety of tumor cells.14 Thus, there is no doubt that 
terpenoids will play an increasingly important role in drug development in the future.  
Another class of compounds that have found great utility in the medical field are the 
multifluorinated arenes.15 They make up an important class of anthropogenic molecules that are 
highly relevant to the pharmaceutical (Figure 1.2),16 material17 and agrichemical industries 
(Figure 1.3).18 It is a well-known fact that fluorine’s electronegativity, size, imparted lipophilicity, 
and electrostatic interactions can influence the chemical reactivity of a compound to a great 
extent.15a-c, 15e In the pharmaceutical area, a number of fluorinated compounds with impressive 
activities have been successfully introduced into the market (Figure 1.2) as anti-depressants, anti-
inflammatory agents, antipsychotic drugs, antimalaria compounds, antiviral agents, anaesthetics 
and steroids.19 Fluorinated compounds are not only resistant to metabolic degradation, owing to 
the strong C–F bond (110 kcal/mol for CH3–F) but also enhance compound lipophilicity. This 
may result in improved passive diffusion of compounds across membranes which can be highly 
desirable when synthesizing drugs.20 
Despite of the great importance that fluorinated molecules demonstrates, methods to 
build these valuable molecules largely depend on just a handful of rather harsh reactions, such as 
the Balz-Schiemann decomposition of an aryl diazonium tetrafluoroborate salt,21 or the high 
temperature (ca 230 oC) halex process.22 This limitation has led to dependence on commercially 
available pre-fluorinated building blocks that can simply be incorporated into other molecules.  
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Almost certainly, this leads to incomplete structural activity relationships studies and 
understanding of fluorine’s effects. 
Figure 1.2: Fluorine in pharmaceutical industry  
 




1.2 Development of photocatalytic defluoroprenylation reactions 
Building on the C–F functionalization strategy put forth by Braun,23 Richmond,24 
Uneyama25 and many others,26 we developed reactions that start with inexpensive highly 
fluorinated arenes, and obtain more complex fluorinated arenes via selective C–F 
functionalization.  As a result, the complexity of the fluorinated molecules that have now become 
accessible far exceeds that of previously synthesized derivatives. In this vein, we were drawn to 
the prenyl motif due to its ubiquity in nature as well as its synthetic versatility. Accomplishing 
this goal would allow us to wed the natural prenyl group and the unnatural perfluoroarenes to 
give hybrid molecules. 
While allylation chemistry is relatively well developed, there are a number of challenges 
that arise while attempting prenylation (Scheme 1.1). Remarkably, this is a result of the two 
additional methyl groups found within the prenyl group. As electrophiles, they are prone to 
elimination.27 Previously, Danishefsky and co-workers27a proposed a cationic prenyl species to 
access prenylated indole alkaloids (Scheme 1.2), but the use of this synthon in enantioselective 
transformations has remained undeveloped. As an anion, prenylation causes regioselectivity 
issues similar to that observed by Kambe.28 He demonstrated that copper(II) chloride could 
facilitate the formation of a prenyl magnesiate that would then undergo uncatalyzed addition to 
the perfluoroarene (Scheme 1.3). The major product results from linear addition of the most 
stable prenyl metal species, but also gives rise to a total of 4 isomers in substantial quantities in a 
combined yield (67%), where the major isomer (2) resulted from the reductive coupling at the 
internal carbon of unsubstituted C–C double bond. Also, the use of a prenyl radical might lead to 





















Scheme 1.3: Kambe’s approach to achieve prenylation on perfluoroarenes 
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Several strategies have been explored to achieve related allylation on perfluoroarenes29 
via C–F functionalization both directly and indirectly. Sukbok and co-workers29f have shown that 
C–H functionalization of highly fluorinated arenes could be attained by using a Cu(NHC) 
catalyst, which has become increasingly relevant with recent improvements to 





Scheme 1.4: C–H allylation of multifluoroarenes  
Allylation on perfluoroarenes has also been achieved by Zhang and co-workers29b in 2011 
(Scheme 1.5). They employed Pd(OAc)2 to carry out this transformation using allyl carbonates 
and partially fluorinated arenes. While this was a great strategy, the reaction conditions required 
relatively high temperatures (over 100 oC) for extended periods (12 hours) and its applicability to 
other fluorinated arenes could only be expanded as far as hydrodefluorination was possible since 
it took place via C–H functionalization.  
 
Scheme 1.5: Palladium catalyzed allylation on polyfluoroarenes using allyl carbonates 
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Other indirect workarounds such as allylation followed by cross-metathesis with isobutene to 
install the remaining geminal dimethyl group have also been employed to accomplish 
prenylation. For instance, Porco and co-workers31 employed indirect allylation followed by cross-
metathesis to achieve prenylation in order to access a class of polyprenylated acylphloroglucinols 
(Scheme 1.6). 
Scheme 1.6: Indirect prenylation via cross-metathesis 
Previously, the Weaver group has shown that upon photocatalytic electron transfer to a 
perfluoroarene, an unstable radical anion forms, which then undergoes mesolytic cleavage to 
extrude a fluoride and a perfluoroaryl radical (Scheme 1.7).30e, 32 This approach solves several 
challenges associated with the short, remarkably strong, and nonpolarizable C–F bond.  As a 
result, the C–F bond is both kinetically and thermodynamically robust. Furthermore, even if the 
bond is broken, and fluoride is formed, fluoride often forms strong and stable metal–F bonds that 
can lead to poor catalyst turnover, thereby making metal-catalyzed processes difficult. Thus, it 
was possible to achieve hydrodefluorination on perfluoroarenes30d by accessing the perfluoroaryl 
radical generated in the reaction which could abstract a hydrogen atom from amine radical cation. 
Perfluoroaryl radical was also utilized to intercept with an alkene to form C–C alkylated product 









Scheme 1.7: Photocatalytic C–F functionalization of perfluoroarenes 
Inspired by the work of Zard who has popularized a number of allyl radicophiles,34 
(olefins with captodative substitution35) we envisioned that such a reagent could be designed to 
facilitate photocatalytic C–F prenylation. Our hope was that this radicophile would intercept the 
photocatalytically generated perfluoroaryl radical to regioselectively generate the key C–C bond. 
The addition would result in an alkyl radical intermediate that we hoped to entice to undergo 
homolytic fragmentation of the ß-leaving group, unmasking the prenyl group. We anticipated that 
the nature of the leaving group would be key to preventing simple hydrogen atom transfer (HAT) 
to the radical.32b Zard and co-workers developed systems that could combine the use of allylic 
alcohol derivatives and readily available xanthates under metal-free conditions to make alkenes, 
aldehydes, saturated and unsaturated ketones through homolytic cleavage of the normally strong 
C−O or C−C bond.34b The activated allylic alcohol derivatives could be synthesized in two steps 
from aldehydes or ketones. They could also be obtained by base-induced opening of epoxides. In 
order to use allylic alcohols for allylation, an easily introducible appendage, (Y, Scheme 1.8), was 
needed that would weaken the strong C−O bond and render it prone to radical fragmentation. In 
an attempt to construct dihydrobenzofurans via a radical addition-cyclization sequence (Scheme 
1.9), they observed pent-4-enenitrile instead of the expected dihydrobenzofuran. The β-
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fragmentation was seen to be faster than either the reversible cyclization or the oxidation step. 
Apart from the gain in entropy, the driving force for β-scission could presumably be the relative 
weakness of the Calkyl−O bond which is weakened due to the formation of a stabilized phenoxyl 
radical. 
 
Scheme 1.8: Allyl alcohol as a radical allylating agent 
Scheme 1.9: Observation of C−O bond fragmentation 
Therefore, Zard demonstrated that the C–O bond of allyl alcohol (80.1 kcal/mol BDE)36 can be 
weakened by converting the hydroxy to an aryloxy group; rendering it susceptible to homolytic 
fragmentation.34, 37 This stabilization is mirrored by the phenoxy radical (PhO–H BDE = 87.3 
kcal/mol) which is more stable than hydroxyl radical (HO–H BDE = 119.3 kcal/mol).38 
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Thus, we began our investigation with the hope of finding a group capable of activating 
the C–O bond towards homolytic fragmentation (Table 1.1). As expected, reaction with isoprenyl 
alcohol (Figure 13, 2a) itself simply results in hydroarylation of the alkene,32c highlighting the 
need for an activating group that can increase the rate of fragmentation. Next, we assessed the 6-
halopyridine motif (2b, 2c) previously explored by Zard37 in lauroyl peroxide mediated transfer 
of xanthates to olefins.  The pyridyl group is conveniently introduced via nucleophilic addition of 
isoprenyl alcohol to the corresponding fluoroarene. We were delighted to see the desired 
prenylated product (3a) in 54% and 43% respectively. The mass balance was primarily comprised 
of hydrodefluorination (HDF) as well as an oxidized version of the desired product, which was 
only identified by GCMS. However, reagents 2b and 2c both underwent competitive [3,3]-
sigmatropic rearrangement, which further complicated the situation and necessitated higher 
reagent loading to compensate for this background reaction that effectively reduced the 
concentration of the prenyl transfer reagent present in solution.  By blocking the ortho position 
with an ester group and increasing the steric demand (2d), we hoped to curtail both the 
rearrangement and the oxidation. Indeed, we halted the rearrangement, but unfortunately, this 
reagent did not deliver the desired prenylated product, but instead yielded only 
hydrodefluorination (HDF) product.  This behavior is perhaps due to competitive and 
unproductive electron transfer to 2d rather than the perfluoroarene. 
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The importance of a weak C–O bond can be observed in low yields of 2e and 2f, which 
would be expected to work better if the C–O bond were to break heterolytically. However, 
substrates 2g and 2h were expected to have a weaker C–O bond and still failed to give improved 
yields. We next evaluated aryl ethers formed from the perfluoroarene (2i and 2j). We were 
pleased to see that these prenyl transfer reagents afforded the desired product, with HDF as the 
only by-product.  It is possible that the fluorines on the reagent serve to prevent rearrangement 
and sterically reduce the activity of the resulting aryloxy radical, potentially involved in the 
formation of the previously observed oxidized product. However, 2k displayed significantly 
decreased activity even though it contained two prenyl groups. Given the positive results and the 
simple nature of 2j we opted to use it for further reaction development. 
Using conditions that had facilitated C–F reductive alkylation,32b using Blue LEDs we 
irradiated methyl pentafluorobenzoate and diisopropylethyl amine (DIPEA) as the electron 
source, along with 6 equiv of 2j at 0 oC.  Previously, we observed that lowering the temperature 
could reduce the amount of competitive HDF in the related C–F arylation reaction.32d We were 
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pleased to see that the desired C−C-coupled product was formed as the major product in decent 
yield, albeit along with a significant amount of HDF product (Table 1.2, entry 1). No prenylation 
or HDF of reagent 2j was observed. Control studies demonstrated the necessity of light, catalyst, 
and amine (entry 2-3).  Carrying out the reaction at lower temperature increased the reaction time 
with no significant improvement in 3a:3a’ ratio (entry 4). While decreasing the DIPEA loading 
slowed the reaction, increasing amine resulted in more HDF (entry 5-7); ultimately, 1.8 
equivalents of DIPEA produced the optimal yield.  There appeared to be a rate dependency on 
catalyst concentration (entries 8 and 9).  Next, we investigated the effect of water on the reaction.  
Unexpectedly, the presence of water significantly accelerated the reaction from 18 h to less than 4 
h and improved product: HDF ratio (entry 10-11). One explanation could be the increase in 
exothermicity of the reaction due to hydration of fluoride.39 An alternative explanation is that 
water acidifies the pentafluorophenol generated in situ. By doping the reaction mixture with 
pentafluorophenol we observed its inhibitory effect on the reaction progress. This effect was 
diminished upon addition of water. An alternative explanation could involve the build up of the 
DIPEA derived iminium, which could competitively quench the photocatalyst.  The addition of 
water could help consume the iminium, preventing unproductive photoquenching.  Recently, Wu 
showed that the competitive reduction product could be minimized by the addition of TEMPO.40 
Therefore, we ran the reaction in the presence of TEMPO and found it initially helped, but 
ultimately slowed the reaction substantially.  
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These data were summarized after a more extensive study that included variations in several 
parameters and careful optimizations. 









The presence of the photocatalyst was required, as indicated by the photocatalyst control 
reaction (Table 1.3, entry 1), in which no conversion was observed. Catalyst A (fac-Ir(ppy)3) 
produced considerable amount of prenylated product (58%) within 21 h. Catalyst B also worked 
well producing 53% of the desired prenylated product within 21 h, however the Pdt:HDF ratio 
was observed to be slightly better in case of Catalyst A. Less reducing Catalyst C also facilitated 
the reaction, resulting in the desired C–C coupled product, albeit at significantly diminished rates 
and with diminished product selectivity. Remarkably, both Catalyst D and E also facilitated 
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prenylation despite an anticipated substantial underpotential. The reaction in these cases was slow 
with no considerable progress after 24 h. 
Table 1.4: Catalyst loading 
 
 
The catalyst loading experiments clearly demonstrated the rate dependency on the concentration 
of the catalyst. Higher concentrations of the catalyst (Table 1.4, entry 1, 2) produced the fastest 
reactions with good conversions within 20 h. The rate of reaction significantly dropped with a 
decrease in concentration of the catalyst.  Interestingly, while water seems to accelerate the 
reaction at 0.25 mol%, this acceleration is reduced at much lower catalyst loadings (compare 
entries 2 & 8 to 6 & 9).  This might be explained by a trace impurity in the reaction mixture that 
effectively quenches the photocatalyst when it too is present only in very trace amounts. 
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Amine A (DIPEA) produced prenylated products in moderate to high yields in 18 h (Table 1.5, 
entry 1-3). Increasing amine concentration to 1.8 equiv produced better conversion as compared 
to 1.2 equiv. When the amine concentration was further increased to 2.5 equiv, it resulted in 
complete consumption of starting material within 18 h but it also produced more of HDF side-
product. Therefore, 1.8 equiv DIPEA was chosen to be the best condition. Amine B (entry 4) was 
also able to form desired prenylated product but in slightly lower yield. Switching the amine to 
Amines C-E (entry 5-8) did not result in any product formation even when the reaction was 
warmed to room temperature (27 oC) instead of running at 0 oC. Compared to Amine A, Amine F 
gave lower conversion of the starting material at 0 oC, as well as at room temperature (entry 9, 
10) probably because of its lower solubility. Amine G did not result in any conversion. 
Table 1.6: Temperature Screening 
Temperature screening revealed yet another important parameter that greatly affected the rate of 
reactions (Table 1.6). Reaction at -10 oC was slow, resulting in 55% prenylated product in 24 h. 
Carrying out the reaction at 0 oC produced 63% of product with reasonable Pdt:HDF ratio. As 
expected, at higher temperature the rate increased (entries 3-4). Though the starting material was 
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fully consumed within 16 h (and 12 h), warmer temperatures always produced relatively more 
HDF, in addition to another minor side product. Entry 2 was chosen to be the optimal temperature 
which produced the cleanest reaction within a reasonable time frame. 
The inclusion of water also played a very important role in improving the reaction rate 
significantly (Table 1.7). The presence of 5 equiv of H2O in the reaction mixture caused the 
reaction to complete in 8 h, as compared to 18 h when the reaction was carried out in the absence 
of water. As the amount of water was increased to 10 equiv (entry 3), the reaction completed 
within 4 h. One plausible explanation could be that the pentafluorophenol (by-product that 
develops during the course of reaction) produces an inhibitory effect under anhydrous reaction 
conditions.  
Table 1.7: Effect of Water 
 
By running an experiment in which pentafluorophenol was intentionally added at the 
beginning of the reaction, the reaction was retarded (Table 1.8). Upon addition of 10 equiv of 
H2O the rate was restored. Furthermore, upon addition of water an improvement can be seen from 
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1.44:1 (product:HDF) in the absence of H2O, to 1.8:1 when 10 equivalents H2O was present 
(entry 3). For comparison, the Pdt:HDF ratio under the standard conditions is 1.9:1. 
One potential explanation is that the water acidifies pentafluorophenol facilitating 
deprotonation and ionization by DIPEA in the reaction, effectively removing phenol-OH by 
converting it to phenoxide. We suspect phenol may serve as an HAT shuttle which can facilitate 
HDF and can generate a problematic persistent radical, which may inhibit catalytic turnover. 
Table 1.8: Experiments investigating the inhibitory effect of pentafluorophenol 
 
We further tested the possibility of using TEMPO to minimize the formation of the competitive 
reduction product.40 TEMPO had a significant effect on the progress of the reaction (Table 1.9). 
TEMPO could abstract an H-atom from the amine radical cation formed during the reaction 
forcing the aryl radical to react with the prenyl source. The Pdt:HDF ratio (3a:3a’) was seen to 
improve during the initial time points. But as the reaction progressed, the Pdt:HDF ratio 
eventually returned to almost the same as observed using standard reaction conditions. Also, the 
presence of TEMPO slowed the overall progress of reaction (from 4 h to 10 h when 0.4 equiv was 
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used) and increasing the amount of TEMPO more further decreased the rate of reaction, thus 
causing incomplete conversion of 1a over extended time possibly due to quenching of the 
necessary aryl radical intermediate. 
Table 1.9: Effect of TEMPO on the rate and selectivity of the reaction 
 Ultimately, using 0.1 M of substrate, 1.8 equiv of DIPEA, 0.3 mol% of fac-Ir(ppy)3 and 
10 equiv of H2O, we began evaluating substrate scope. Under these conditions a number of 
perfluoroarenes smoothly underwent C–F defluoroprenylation in good to modest yields. The 
reaction tolerates a number of functional groups including esters (Table 1.10, 3a-3c), nitriles (3d), 
CF3 (3e), and perfluoroheterocyclic arenes (3g).  Hexafluorobenzene, devoid of any additional 
electron-withdrawing functional group also proceeded to form 3f, though it required the use of 6-
halopyridyl prenyl source 2b as the prenyl source.  Specifically, in the presence of prenyl transfer 
reagent 2j, hexafluorobenzene remained unchanged. 3h-l are noteworthy as they demonstrate the 
preference for chlorine fragmentation over that of fluorine despite the position on the ring. Given 
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that many chlorofluoro-starting materials are commercially available, it provides a convenient 
strategy for accessing complementary regioisomers.  When a chlorine was placed at the site of 
preferential fluorine fragmentation (4 position for pyridine), it displayed moderately shorter 
reaction time compared to pentafluoropyridine (i.e. 3h compared to 3g). This could be because 
fragmentation of chloride ion is more exothermic than fluoride, resulting in a faster fragmentation 
event. Furthermore, the presence of chlorine substituents create greater steric demand than 
fluorine substituents, and could result in a relative increase the ground state energy.41 Likewise, 
steric repulsion between the substituents in the radical anion may also accelerate its breakdown, 
leading to faster fragmentation. Interestingly, prenylation at the meta position was also possible 
but required longer reaction time (3i and 3j vs 3g).  













While the photocatalytically enduced mesolytic fragmentation of fluoride has been highly 
resgioselective, the fragmentation of chloride from multichlorinated arenes is generally less 
regioselective and displays a temperature dependent behavior (3g vs 3k and 3l), but still results in 
useful selectivities.  This method can be used to access heterocyclic substituted perfluoroarenes 
like oxazoles (3m), benzoimidazoles (3n) and benzothiazoles (3o).  In all these reactions, HDF 
made up the mass balance.  
Looking to expand the utility of the method, we applied this strategy towards allylation of 
perfluoroarenes.  As expected, allylation with transposition of the double bond proceeded 
smoothly to yield 5a-5f in good yield (Table 1.11).  Substitution at both the ß-position (5c and 
5d), and the γ-position were well tolerated (5e and 5f).  While the yield was acceptable, in the 
case of unsymmetric 5f, the E/Z-selectivity was very modest (1.3:1) and did not display 
significant temperature dependence, which may limit its use in cases where the olefin geometry is 
essential. 












Encouraged by our success with prenyl transfer, we hoped to extend our strategy to 
geranyl transfer which would add a 10 carbon unit.  Using the same optimized conditions, we 
reacted perfluoroarenes with pentafluoroisogeranyl ether (6, Table 1.12).  We were concerned 
that the alkyl radical formed upon addition to the alkene would undergo intramolecular addition 
to the additional olefin (i.e. 5-exo-trig cyclization) faster than fragmentation of the 
pentafluorophenoxy radical. Thus, we were pleased to obtain the geranylated product in similar 
yields to the prenylation reaction.  A striking difference, however, was that the reaction took 
place preferentially at the position ortho to the substituent on the perfluoroaryl ring (c.a. ortho: 
para 1.6:1). This is particularly noteworthy as it is the first time that we have observed an external 
reagent capable of influencing the C–F regioselectivity in a photocatalytic C–F functionalization. 
While we are uncertain about the underlying cause of this change in regioselectivity, our working 
hypothesis is that there is an attractive interaction between 6 and the radical anion of 1.  This 
results in an intermolecular complex which sterically perturbs the ortho C–F bond, presumably 
causing deviation from planarity, and resulting in a faster fragmentation. 










While, 7a-7d were produced as a mixture of ortho-para isomers, it demonstrated perfect 
diastereoselectivity, giving only the E-alkene. This selectivity is in stark contrast to the 
unsymmetric allyl derivative, 5f, which was produced as a mixture.  Again, the origin of this is 
not clear. 
1.3 Summary  
In conclusion, we have developed a strategy and along with reagents that enable 
photocatalytic defluoro-allylation, -prenylation, and -geranylation of perfluoroarenes.  We 
observed that the addition of water leads to substantial rate enhancements.  Further, as we moved 
from prenylation to geranylation, we observed a change in the regioselectivity of the major 
product from para-C–F functionalization to ortho-C–F functionalization. Our approach allows 
direct allyl, prenyl and geranyl substitution of C–F bonds using very mild conditions and short 
reaction times.  This strategy should facilitate investigations involving the synthesis of hybrid 
fluorinated analogs of natural products.  Additionally, this reaction presents a number of 
interesting mechanistic facets which are currently being studied, and the findings will be reported 
in due course. 
1.4 Experimental Section 
General Experimental 
All reagents were obtained from commercial suppliers (Sigma-Aldrich, Oakwood chemicals, Alfa 
Aesar, Matrix Scientific) and used without further purification unless otherwise noted. 
Acetonitrile (CH3CN) was dried over molecular sieves. N,N-diisopropylethylamine was 
purchased from Sigma-Aldrich and stored over KOH pellets. Photocatalyst tris(2-phenyl 
pyridinato-C2, N)iridium(III)[Ir(ppy)3], 99%(purity), was synthesized according to a literature 
procedure.32c Photocatalyst tris[4,4’-bis(tert-butyl)-2,2’-bipyridine]ruthenium(II) 
hexafluorophosphate and tris(4,4’-dimethyl-2,2’-bipyridine)ruthenium(II) hexafluorophosphate 
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were purchased from Aspira Chemical. Isopropyl 2,3,4,5,6-pentafluorobenzoate, tert-butyl 
2,3,4,5,6-pentafluorobenzoate, 4-chloro-2,3,5,6-tetrafluoropyridine, 3,4-dichloro-2,5,6-
trifluoropyridine, 3,4,5-trichloro-2,6-difluoropyridine, 2-(perfluorophenyl)benzo[d]oxazole, 2-
(perfluorophenyl)-1H-benzo[d]imidazole and 2-(perfluorophenyl)benzo[d]thiazole were 
synthesized according to literature procedures.30d, 42 Reactions were monitored by 19F and GC-MS 
(QP 2010S, Shimadzu equipped with auto sampler). NMR spectra were obtained on a 400 MHz 
Bruker Avance III spectrometer and 400 MHz Unity Inova spectrometer. 1H and 13C NMR 
chemical shifts are reported in ppm relative to the residual protio solvent peak (1H, 13C) and 19F 
NMR shifts are reported using fluorobenzene as a standard. Melting points were determined on a 
Mel-Temp apparatus and are uncorrected. GC analyses were carried out using a QP 2010S 
Shimadzu, equipped with an auto sampler. Isolations were carried out using a Teledyne Isco 
Combiflash Rf 200i flash chromatograph with Sorbtech Rf normal phase silica (4 g, or 12 g 
columns). Some isolations were performed using Sorbent Technologies Silica Prep TLC Plates, 
w/UV254, glass backed, 1000 μm, 20 x 20 cm, and were visualized with ultraviolet light. 
Substrate syntheses were monitored by thin layer chromatography (TLC) obtained from Sorbent 
Technologies; Silica XHL TLC Plates, w/UV254, glass backed, 250 μm, and were visualized 
with ultraviolet light or potassium permanganate. No attempts were made to report 13C spectra of 
volatile compounds. 
Photocatalytic Reaction Set up 
Photocatalytic reactions were set up in a light bath as described below. Strips of blue LEDs (18 
LEDs/ft.) were purchased from Solid Apollo. The strips (4.9 ft) were wrapped around on the 
walls of a glass crystallization dish, secured with masking tape and then the dish was wrapped 
with aluminum foil. A lid which rest on the top was fashioned from cardboard and holes were 
made such that NMR tubes were held firmly in the cardboard lid which was placed on the top of 
the bath. Isopropanol/water bath was prepared such that the tubes were submerged, and it was 
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maintained at 0 oC with the aid of a chiller that circulated coolant through a coil of copper tubing 
placed in the bath. In some cases, the same light bath set up was used with water in it which was 
maintained at 45 oC with the aid of a sand bath connected to a thermostat.30d 
 
 
Figure 1.4: Photocatalytic reaction set up using light bath 
Synthesis of Substrates  
General Procedure A for synthesis of aryl ethers: 
To a stirred solution of alcohol (1.0 equiv) in THF (anhyd) in a flame-dried 250 mL round-
bottomed flask, was added NaH (1.3 equiv) portion wise under Ar. The resulting mixture was 
stirred for 20 minutes at room temperature. Hexafluorobenzene (1.3-4.0 equiv) was then added all 
at once and the reaction was monitored by TLC until the spot for alcohol disappeared. After 
completion, the reaction mixture was slowly quenched with water. The aqueous phase was 
extracted with diethyl ether, and the combined organic extracts were washed with brine (3 x 30 
mL), dried over MgSO4, filtered and concentrated in vacuo. The crude material was purified by 




Strips of blue LEDs 
Isopropanol/water 
Copper coil tubing 
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1-(Allyloxy)-2,3,4,5,6-pentafluorobenzene (4a) was synthesized using general procedure A. 2-
Propen-1-ol (3.51 mL, 51.6 mmol), NaH (1.61 g, 66.6 mmol) was stirred in anhyd. THF (30 mL) 
at room temperature for 20 minutes. Then hexafluorobenzene (7 mL, 66.6 mmol) was added and 
stirred for 18 h. The crude residue was purified by automated flash chromatography using 
hexane:ethyl acetate (0 % EtOAc for 0-15 cv and ramped to 50 % EtOAc for 15-25 cv and then 
held at 100% EtOAc 25-35 cv) on a 24 g silica column to afford the product in 85% yield (9.8 g, 
43.8 mmol) as a colorless liquid. 




1,2,3,4,5-Pentafluoro-6-((2-methylallyl)oxy)benzene (4b) was synthesized using general 
procedure A. 2-Methylprop-2-en-1-ol (3.51 mL, 41.6 mmol), NaH (1.29 g, 54.1 mmol) was 
stirred in anhyd. THF (30 mL) at room temperature for 20 minutes. Then hexafluorobenzene 
(6.24 mL, 54.1 mmol) was added and stirred for 18 h.  The crude residue was purified by 
automated flash chromatography using hexane:ethyl acetate (0% EtOAc for 0-15 cv and ramped 
to 50% EtOAc for 15-25 cv and then held at 100% EtOAc 25-35 cv) on a 24 g silica column to 
afford the product in 86% yield (8.52 g, 35.77 mmol) as a colorless liquid. 
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Synthesis of 2-fluoro-6-((2-methylbut-3-en-2-yl)oxy)pyridine (2b) 
 
 
2-Fluoro-6-((2-methylbut-3-en-2-yl)oxy)pyridine (2b) was synthesized using a modified 
version of general procedure A. 2-Methylbut-3-en-2-ol (3 mL, 28.7 mmol), NaH (0.908 g, 37.7 
mmol) was stirred in anhyd. THF (35 mL) at room temperature for 20 minutes. Then, 2,6-
difluoropyridine (3.12 mL, 34.4 mmol) (rather than C6F6) was added and stirred for 14 h. The 
crude residue was purified by automated flash chromatography using hexane:ethyl acetate (0% 
EtOAc for 0-15 cv and ramped to 50% EtOAc for 15-25 cv and then held at 100% EtOAc 25-35 
cv) on a 24 g silica column to afford the product in 88% yield (4.57 g, 25.26 mmol) as a colorless 
liquid. 
Synthesis of 2-chloro-6-((2-methylbut-3-en-2-yl)oxy)pyridine (2c) 
 
 
2-Chloro-6-((2-methylbut-3-en-2-yl)oxy)pyridine (2c) was synthesized using a modified 
version of general procedure A. 2-Methylbut-3-en-2-ol (2 mL, 19 mmol), NaH (0.684 g, 28.5 
mmol) was stirred in anhyd THF (35 mL) at room temperature for 20 minutes. Then 2-chloro-6-
fluoropyridine (3 g, 22.8 mmol) (rather than C6F6) was added and stirred for 14 h. The crude 
residue was purified by automated flash chromatography using hexane:ethyl acetate (0% EtOAc 
for 0-15 cv and ramped to 50% EtOAc for 15-25 cv and then held at 100% EtOAc 25-35 cv) on a 
24 g silica column to afford the product in 87% yield (3.25 g, 16.53 mmol) as a colorless liquid. 
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Synthesis of methyl 2-((2-methylbut-3-en-2-yl)oxy)nicotinate (2d) 
 
 
Methyl 2-((2-methylbut-3-en-2-yl)oxy)nicotinate (2d) was synthesized using a modified 
version of general procedure A. 2-methylbut-3-en-2-ol (1.7 mL, 16.11 mmol), NaH (0.58 g, 
24.16 mmol) was stirred in anhyd THF (35 mL) at room temperature for 20 minutes. Then methyl 
2-fluoronicotinate (3 g, 19.33 mmol) (rather than C6F6) was added, heated at 50 oC and stirred for 
9 h. The crude residue was purified by automated flash chromatography using hexane:ethyl 
acetate (0% EtOAc for 0-15 cv and ramped to 50% EtOAc for 15-25 cv and then held at 100% 
EtOAc 25-35 cv) on a 24 g silica column to afford the product in 44% yield (1.568 g, 7.088 
mmol) as a colorless liquid. 
 




2,3,5,6-Tetrafluoro-4-((2-methylbut-3-en-2-yl)oxy)pyridine (2i) was synthesized using a 
modified version of general procedure A. 2-methylbut-3-en-2-ol (3 mL, 28.7 mmol), NaH (0.91 
g, 37.31 mmol) was stirred in anhyd THF (40 mL) at room temperature for 20 minutes. Then 
pentafluoropyridine (3.8 mL, 34.44 mmol) (rather than C6F6) was added, heated at 70 oC and 
stirred for 5 h. The crude residue was purified by automated flash chromatography using 
hexane:ethyl acetate (0% EtOAc for 0-15 cv and ramped to 50% EtOAc for 15-25 cv and then 
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held at 100% EtOAc 25-35 cv) on a 24 g silica column to afford the product in 35% yield (2.362 
g, 10.04 mmol) as a colorless liquid. 




1,2,3,4,5-Pentafluoro-6-((2-methylbut-3-en-2-yl)oxy)benzene (2j) was synthesized using 
general procedure A. 2-Methylbut-3-en-2-ol (5.2 mL, 49.44 mmol), NaH (1.54 g, 64.2 mmol) 
was stirred in anhyd. THF (40 mL) at room temperature for 20 minutes. Then hexafluorobenzene 
(8 mL, 69.2 mmol) was added and stirred for 18 h. The crude residue was purified by automated 
flash chromatography using hexane:ethyl acetate (0% EtOAc for 0-15 cv and ramped to 50% 
EtOAc for 15-25 cv and then held at 100% EtOAc 25-35 cv) on a 24 g silica column to afford the 
product in 83% yield (10.3 g, 41.03 mmol) as a colorless liquid. 




1,2,4,5-Tetrafluoro-3,6-bis((2-methylbut-3-en-2-yl)oxy)benzene (2k) was synthesized using a 
modified version of general procedure A. 2-Methylbut-3-en-2-ol (5.6 mL, 53.7 mmol), NaH 
(1.28 g, 53.7 mmol) was stirred in anhyd. THF (40 mL) at room temperature for 20 minutes. Then 
hexafluorobenzene (1.24 mL, 10.7 mmol) was added and stirred at 50 oC overnight. The crude 
residue was purified by automated flash chromatography using hexane:ethyl acetate (0% EtOAc 
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for 0-15 cv and ramped to 50% EtOAc for 15-25 cv and then held at 100% EtOAc 25-35 cv) on a 
24 g silica column to afford the product in 51% yield (1.74 g, 5.45 mmol) as a colorless liquid. 
Synthesis of 1-((3,7-dimethylocta-1,6-dien-3-yl)oxy)-2,3,4,5,6-pentafluorobenzene (6) 
 
 
1-((3,7-Dimethylocta-1,6-dien-3-yl)oxy)-2,3,4,5,6-pentafluorobenzene (6) was synthesized 
using general procedure A. Linalool (1.8 mL, 9.9 mmol), NaH (0.31 g, 12.9 mmol) was stirred 
in anhyd. THF (40 mL) at room temperature for 20 minutes. Then hexafluorobenzene (1.5 mL, 
12.9 mmol) was added and stirred for 18 h. The crude residue was purified by automated flash 
chromatography using hexane:ethyl acetate (0% EtOAc for 0-15 cv and ramped to 50% EtOAc 
for 15-25 cv and then held at 100% EtOAc 25-35 cv) on a 24 g silica column to afford the 
product in 81% yield (2.56 g, 8.02 mmol) as a colorless liquid. 
General Procedure B for synthesis of aryl ethers via Grignard reagent: 
To a suspension of fresh Mg turnings in anhydrous THF was added catalytic amount of I2. A 
solution of vinyl bromide (1 M in THF) was then added, and the mixture was heated to initiate 
the Grignard reaction. The remainder of vinyl bromide solution was added at a rate to maintain 
gentle reflux. After complete addition, a solution of corresponding ketone in THF was added over 
15 minutes and the reaction was left to stir at room temperature overnight. The reaction was 
carefully quenched with saturated NH4Cl solution, and then extracted with ether (4x40 mL). The 
ether extract was washed with brine (40 mL), dried over MgSO4 and then concentrated using 
rotatory evaporator. The product was isolated using column chromatography. 
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1,2,3,4,5-pentafluoro-6-((1-vinylcyclohexyl)oxy)benzene (4c) was synthesized using general 
procedure B followed by general procedure A. A solution of 1 M vinyl bromide in THF (32 
mL, 32 mmol) was added to Mg turnings (0.77 g) in THF (45 mL) and heated to initiate Grignard 
reaction. It was followed by addition of cyclohexanone (2.54 mL, 24.6 mmol) over 15 minutes 
and left to stir overnight at room temperature. The crude residue was purified by automated flash 
chromatography using hexane:ethyl acetate (0% EtOAc for 0-10 cv, ramped to 10% EtOAc for 
10-25 cv, ramped again to 50% for 25-30 cv and then held at 100% EtOAc for 30-40 cv) on a 24 
g silica column to afford 1-vinylcyclohexan-1-ol in 29.7% yield (0.92 g, 7.3 mmol) as a pale 
yellow liquid. 
1-vinylcyclohexan-1-ol was then used to carry out general procedure A for synthesis of aryl 
ether. 1-vinylcyclohexan-1-ol (0.96 mL, 7.3 mmol), NaH (0.262 g, 10.94 mmol) was stirred in 
anhyd. THF (40 mL) at room temperature for 20 minutes. Then hexafluorobenzene (1.26 mL, 
10.94 mmol) was added and stirred at the same temperature for 18 h. The crude residue was 
purified by automated flash chromatography using hexane:ethyl acetate (0% EtOAc for 0-15 cv 
and ramped to 50% EtOAc for 15-25 cv and then held at 100% EtOAc 25-35 cv) on a 24 g silica 
column to afford 1,2,3,4,5-pentafluoro-6-((1-vinylcyclohexyl)oxy)benzene (4c) in 63% yield 
(1.34 g, 4.58 mmol) as a colorless liquid. 
34 
 





1,2,3,4,5-pentafluoro-6-((3-methyloct-1-en-3-yl)oxy)benzene (4d) was synthesized using 
general procedure B followed by general procedure A. A solution of 1 M vinyl bromide in 
THF (36 mL, 36 mmol) was added to Mg turnings (0.864 g) in THF (45 mL) and heated to 
initiate Grignard reaction. It was followed by addition of heptan-2-one (2.8 mL, 20.0 mmol) over 
15 minutes and left to stir overnight at room temperature. The crude residue was purified by 
automated flash chromatography using hexane:ethyl acetate (0% EtOAc for 0-10 cv, ramped to 
10% EtOAc for 10-25 cv, ramped again to 50% for 25-30 cv and then held at 100% EtOAc for 
30-40 cv) on a 24 g silica column to afford 3-methyloct-1-en-3-ol in 44% yield (1.25 g, 8.8 
mmol) as a colorless liquid. 
3-methyloct-1-en-3-ol was then used to carry out general procedure A for synthesis of aryl 
ether. 3-methyloct-1-en-3-ol (1.49 mL, 8.8 mmol), NaH (0.316 g, 13.2 mmol) was stirred in 
anhyd. THF (40 mL) at room temperature for 20 minutes. Then hexafluorobenzene (4.07 mL, 
35.2 mmol) was added and refluxed for 6 h. The crude residue was purified by automated flash 
chromatography using hexane:ethyl acetate (0% EtOAc for 0-15 cv and ramped to 50% EtOAc 
for 15-25 cv and then held at 100% EtOAc 25-35 cv) on a 24 g silica column to afford 1,2,3,4,5-






(E)-1,2,3,4,5-pentafluoro-6-((3,7,11-trimethyldodeca-1,6,10-trien-3-yl)oxy)benzene (8) was 
synthesized using general procedure B followed by general procedure A. A solution of 1 M 
vinyl bromide in THF (25 mL, 25 mmol) was added to Mg turnings (0.519 g) in THF (45 mL) 
and heated to initiate Grignard reaction. It was followed by addition of (E)-6,10-dimethylundeca-
5,9-dien-2-one (3.71 mL, 16.67 mmol) over 15 minutes and left to stir overnight at room 
temperature. The crude residue was purified by automated flash chromatography using 
hexane:ethyl acetate (0 % EtOAc for 0-10 cv, ramped to 10 % EtOAc for 10-25 cv, ramped again 
to 50% for 25-30 cv and then held at 100% EtOAc for 30-40 cv) on a 24 g silica column to afford 
(E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol in 32.7% yield (1.21 g, 5.45 mmol) as a pale 
yellow liquid. 
(E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol was then used to carry out general procedure A 
for synthesis of aryl ether. (E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol (1.38 mL, 5.45 mmol), 
NaH (0.261 g, 10.9 mmol) was stirred in anhyd. THF (45 mL) at room temperature for 20 
minutes. Then hexafluorobenzene (0.95 mL, 8.17 mmol) was added and refluxed for 9 h. The 
crude residue was purified by automated flash chromatography using hexane:ethyl acetate (0% 
EtOAc for 0-15 cv and ramped to 50% EtOAc for 15-25 cv and then held at 100% EtOAc 25-35 
cv) on a 24 g silica column to afford (E)-1,2,3,4,5-pentafluoro-6-((3,7,11-trimethyldodeca-
1,6,10-trien-3-yl)oxy)benzene (8) in 61% yield (1.29 g, 3.32 mmol) as a colorless liquid. 
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General procedure C for synthesis of aryl ether via acetylation: 
 
To a flame dried 250 mL round bottom flask was added 2-methylbut-3-en-2-ol (2.5 mL, 23 
mmol), Et3N (10.4 mL, 87.4 mmol), DMAP (0.04 mL, 0.184 mmol) and DCM (20 mL) via 
syringe. Flask was cooled in ice-bath and acetic anhydride (7.2 mL, 87.4 mmol) was added 
dropwise with constant stirring. The resulting solution was stirred under an Ar atmosphere at 
room temperature and was monitored by TLC (hexane : ethyl acetate 95:5) until no alcohol was 
observed. The mixture was washed with NaHCO3 (2 x 150 mL), 10% NaOH (2 x 50 mL), brine 
(50 mL) and dried over MgSO4. Solvent was removed in vacuo and crude product was obtained 
as a yellow oil which was distilled (130-150 oC at 760 mm Hg) to yield 2-methylbut-3-en-2-yl 
acetate in 91% yield (2.9 mL, 20.93 mmol) as a colorless liquid. 
General Procedure D for synthesis of aryl ether using dimethyl phosphorochloridate : 
 
 
Dimethyl phosphorochloridate (3.61g, 25 mmol) was added to a solution of 2-methylbut-3-en-2-
ol ( 1.94 g, 22.5 mmol) and pyridine (2.0 mL) in CH2Cl2 (30 mL) at 0 oC over 5 minutes. The 
resulting white slurry was stirred for 6 h at room temperature. The reaction mixture was diluted 
with diethyl ether and was washed successfully with a 10% HCl solution, saturated NaHCO3 (2 x 
50 mL) and brine (3 x 50 mL). The organic layer was dried over anhydrous MgSO4. After 
removal of the solvent in vacuo, the crude product was purified by automated flash 
chromatography using hexane:ethyl acetate (0% EtOAc for 0-15 cv and ramped to 50% EtOAc 
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for 15-25 cv and then held at 100% EtOAc 25-35 cv) on a 24 g silica column to afford dimethyl 
(2-methylbut-3-en-2-yl) phosphate in 76% yield (3.32 g, 17.1 mmol) as a colorless liquid. 
General Procedure E for synthesis of aryl ether from pyran :  
 
To a solution of 2-methylbut-3-en-2-ol (0.9 ml, 9 mmol) in DCM (30 mL) 2,3-dihydro-4H-pyran 
(0.8 mL, 9 mmol) and trifluoroacetic acid (0.1 mL, 1.8 mmol) were added. The reaction was 
stirred at room temperature and monitored by TLC. After completion of the reaction, it was 
quenched with NaHCO3 and extracted with DCM. The organic phase was then washed with 
water and brine, dried over MgSO4, and concentrated in vacuo. The crude product was purified 
by automated flash chromatography using hexane : ethyl acetate (0% EtOAc for 0-15 cv and 
ramped to 30% EtOAc for 15-25 cv and then held at 100% EtOAc 25-35 cv) on a 24 g silica 
column to afford 2-((2-methylbut-3-en-2-yl)oxy)tetrahydro-2H-pyran in 70% yield (1.07 g, 6.3 
mmol) as a colorless oil. 
Working mechanism 
We believe that the reaction progresses with excitation of Ir(ppy)3 in the presence of blue LEDs to 
form a long lived triplet excited state. This further undergoes endothermic single electron transfer 
from DIPEA forming the radical anion via reductive quenching. It can then transfer an electron 
exothermically to the perfluoroarene (A) resulting in the formation of a perfluoroaryl radical 
anion (I1) that causes extrusion of fluoride ion to form a perfluoroaryl radical (I2). This 
perfluoroaryl radical (I2) in turn attacks the prenylating agent (B) selectively at the unsubsituted 
terminus of the alkene to generate a new radical (I3) followed by the loss of a phenoxy radical 





Figure 1.5: Working mechanism 
Photocatalytic Reactions on Perfluoroarenes 
We believe that the reaction progresses with excitation of Ir(ppy)3 in the presence of blue LEDs 
to form a long lived triplet excited state. This further undergoes endothermic single electron 
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transfer from DIPEA forming the radical anion via reductive quenching. It can then transfer an 
electron exothermically to the perfluoroarene (A) resulting in the formation of a perfluoroaryl 
radical anion (I1) that causes extrusion of fluoride ion to form a perfluoroaryl radical (I2). This 
perfluoroaryl radical (I2) in turn attacks the prenylating agent (B) selectively at the unsubsituted 
terminus of the alkene to generate a new radical (I3) followed by the loss of a phenoxy radical 
(I4) and results in the desired C–C coupled prenylated product (C). The perfluoroaryl radical (I2) 
generated upon fluoride fragmentation could also undergo undesired hydrogen atom transfer from 
the amine radical cation (I5) (and potentially the amine D, α C–H BDE of 91 kcal/mol)44 to form 
undesired HDF product. The phenoxy radical (I4) generated (BDE C6H5O–H is 87.6 kcal/mol)45 
during the course of reaction is capable of abstracting hydrogen atom from amine radical cation 
(I5, α C–H BDE ˷ 42 kcal/mol)46 to form pentafluorophenol and generate an iminium ion (I6). We 
believe that in the presence of water, the equilibrium is shifted towards the ionic forms (the left).  
Our control studies with C6F5OH demonstrate its inhibitory and deleterious effect in the absence 
of water (see above).  This may be because it serves as a good HAT donor. We speculate that the 
phenolate (I7) could also have a beneficial role by attacking the iminium ion (I6) to form the N-
acetal species (I8). 
General procedure F for photocatalytic allylation reaction 
An NMR tube was charged with fluoroarene (0.1 mmol, 1.0 equiv), allyl-OAr (0.6 mmol, 6 
equiv), N,N-diisopropylethylamine (0.18 mmol, 1.8 equiv), distilled water ( 1 mmol, 10 equiv),  
fac-tris(2- phenyl pyridinato-C2, N) Iridium(III) (Ir(ppy)3) (0.3 mM, 1 mL in MeCN), sealed 
40 
 
glass capillary containing C6D6 and was capped with an NMR septum (Ace glass, part no. 9096-
25). When reaction was run in greater than 0.1 mmol of fluoroarene, more than one NMR tube 
was used to set up the reaction and each NMR tube had 1 mL of reaction mixture. The reaction 
was degassed via Ar bubbling for 15 min at 0 °C (to avoid evaporation of N,N 
diisopropylethylamine and other volatile starting materials) and then placed in a light bath (vide 
supra) such that the lower portion of the tube was submerged under the isopropanol/water bath. 
The reaction was monitored periodically by 19F NMR (care was taken to exclude light while in 
transit). After the complete consumption of starting material, CH3CN was removed via rotavap. 
The crude material was purified using prep TLC plate 10:1 hexane:ether. If the reaction did not 
go to completion with the first addition of N,N diisopropylethylamine, an additional 0.2 - 1.2 
equiv of N,N -diisopropylethylamine was added to the reaction. Then the reaction was re-
degassed and returned to the light bath. This sequence was repeated until the reaction reached 
completion as judged by 19F NMR. 
General procedure F was followed using methyl 2,3,4,5,6-pentafluorobenzoate 
(14.75 μL, 0.1 mmol, 1 equiv), 1-(allyloxy)-2,3,4,5,6-pentafluorobenzene (97.5 
μL, 0.6 mmol, 6 equiv), N,N-diisopropylethylamine (31.3 μL, 0.18 mmol, 1.8 
equiv), distilled water (18 μL, 1 mmol, 10 equiv) and 1.0 mL of stock solution of 
Ir(ppy)3 (0.16 mg, 0.0003 mmol, 0.003 equiv) in CH3CN was used. The crude material was 
purified by using Prep TLC 10:1 hexane:diethyl ether to afford methyl 4-allyl-2,3,5,6-
tetrafluorobenzoate (5a) as a colorless liquid in 72% 19F NMR yield and 66% isolated yield 
(14.89 mg, 0.06 mmol). 19F NMR (376 MHz, CDCl3) δ -140.04 – -140.19 (m, 2F), -143.12 (td, J 
= 15.8, 4.8 Hz, 2F). 1H NMR (400 MHz, CDCl3) δ 5.94 – 5.82 (m, 1H), 5.12 (d, 2H), 3.97 (s, 
3H), 3.50 (d, J = 6.3 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 160.4, 146.1 – 143.6 (ddd, J = 12.9, 
6.4, 4.8 Hz), 145.8 – 143.3 (dt, J = 15.9, 4.6 Hz), 132.2, 121.9 (t, J  18.4 Hz), 117.6, 110.6 (t, J = 
15.7 Hz), 53.2, 27.1. GC/MS (m/z, relative intensity) 248 (M+, 48), 229 (2), 217 (100), 169 (28). 
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General procedure F was followed using methyl pentafluorobenzonitrile (12.6 
μL, 0.1 mmol, 1 equiv), 1-(allyloxy)-2,3,4,5,6-pentafluorobenzene (97.6 μL, 0.6 
mmol, 6 equiv), N,N-diisopropylethylamine (31.3 μL, 0.18 mmol, 1.8 equiv), 
distilled water (18 μL, 1 mmol, 10 equiv) and 1.0 mL of stock solution of Ir(ppy)3 
(0.16 mg, 0.0003 mmol, 0.003 equiv) in CH3CN was used. The crude material was purified by 
using Prep TLC 10:1 hexane:diethyl ether to afford 4-allyl-2,3,5,6-tetrafluorobenzonitrile (5b) 
as a colorless liquid in 81% 19F NMR yield and 72% isolated yield (15.48 mg, 0.07 mmol). Not 
much effort was given to evaporate the solvents due to low volatility of compound. The crude 
product also contained hydrodefluorinated product. 19F NMR (376 MHz, CDCl3) δ -132.67 – -
133.24 (m, 2F), -133.68 – -134.38 (m, 2F, minor), -140.50 (td, J = 15.8, 4.8 Hz, 2F), -140.94 – -
141.51 (m, 2F, minor). 1H NMR (400 MHz, CDCl3) δ 5.89 – 5.68 (m, 1H), 5.09 (d, 2H), 3.47 (d, 
2H).  
General procedure F was followed using methyl 2,3,4,5,6-pentafluorobenzoate 
(14.75 μL, 0.1 mmol, 1 equiv), 1,2,3,4,5-pentafluoro-6-((2-
methylallyl)oxy)benzene (107.3 μL, 0.6 mmol, 6 equiv), N,N-
diisopropylethylamine (31.3 μL, 0.18 mmol, 1.8 equiv), distilled water (18 μL, 1 
mmol, 10 equiv) and 1.0 mL of stock solution of Ir(ppy)3 (0.16 mg, 0.0003 mmol, 0.003 equiv) in 
CH3CN was used. The crude material was purified by using Prep TLC 10:1 hexane:diethyl ether 
to afford methyl 2,3,5,6-tetrafluoro-4-(2-methylallyl)benzoate (5c) as a colorless liquid in 74% 
19F NMR yield and 68% isolated yield (18.34 mg, 0.07 mmol). 19F NMR (376 MHz, CDCl3) δ -
140.02 – -140.44 (m, 2F), -142.50 (td, J = 15.8, 4.8 Hz, 2F). 1H NMR (400 MHz, CDCl3) δ 4.85 
(s, 1H), 4.65 (s, 1H), 3.98 (s, 3H), 3.44 (s, 2H), 1.78 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 
160.4, 146.2 – 143.8 (ddd, J = 12.9, 6.4, 4.8 Hz), 145.8 – 143.2 (dt, J = 15.9, 4.6 Hz), 140.4, 
121.9 (t, J = 18.4 Hz), 112.8, 110.6 (t, J = 15.7 Hz), 53.2, 31.3 – 30.6 (m), 22.3. GC/MS (m/z, 
relative intensity) 262 (M+, 64), 247 (15), 231 (100). 
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General procedure F was followed using 2,3,4,5,6-pentafluorobenzonitrile (12.6 
μL, 0.1 mmol, 1 equiv), 1,2,3,4,5-pentafluoro-6-((2-methylallyl)oxy)benzene 
(107.3 μL, 0.6 mmol, 6 equiv), N,N-diisopropylethylamine (31.3 μL, 0.18 mmol, 
1.8 equiv), distilled water (18 μL, 1 mmol, 10 equiv) and 1.0 mL of stock solution 
of Ir(ppy)3 (0.16 mg, 0.0003 mmol, 0.003 equiv) in CH3CN was used. The crude material was 
purified by using Prep TLC 10:1 hexane:diethyl ether to afford 2,3,5,6-tetrafluoro-4-(2-
methylallyl)benzonitrile (5d) as a colorless liquid in 85% 19F NMR yield and 78% isolated yield 
(17.86 mg, 0.08 mmol). 19F NMR (376 MHz, CDCl3) δ -133.06 (td, J = 17.4, 7.1 Hz, 2F), -139.86 
(td, J = 16.8, 7.0 Hz, 2F). 1H NMR (400 MHz, CDCl3) δ 4.88 (s, 1H), 4.66 (s, 1H), 3.48 (s, 2H), 
1.79 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 148.2 – 145.6 (dt, J = 16.4, 3.6 Hz), 146.3 – 143.4 
(m), 139.7, 125.8 (t, J = 18.4 Hz), 113.5, 107.6 (t, J = 3.7 Hz), 92.4, 31.2, 22.3. GC/MS (m/z, 
relative intensity) 229 (M+, 55), 214 (34), 194 (25). 
General procedure F was followed using methyl 2,3,4,5,6-pentafluorobenzoate 
(14.8 μL, 0.1 mmol, 1 equiv), 1,2,3,4,5-pentafluoro-6-((1-
vinylcyclohexyl)oxy)benzene(125 μL, 0.6 mmol, 6 equiv), N,N-
diisopropylethylamine (31.3 μL, 0.18 mmol, 1.8 equiv), distilled water (18 μL, 1 
mmol, 10 equiv) and 1.0 mL of stock solution of Ir(ppy)3 (0.16 mg, 0.0003 
mmol, 0.003 equiv) in CH3CN was used. The crude material was purified by using Prep TLC 
10:1 hexane:diethyl ether to afford methyl 4-(2-cyclohexylideneethyl)-2,3,5,6-
tetrafluorobenzoate (5e) as a colorless liquid in 68% 19F NMR yield and 61% isolated yield 
(18.96 mg, 0.06 mmol). 19F NMR (376 MHz, CDCl3) δ -140.24 – -140.41 (m, 2F, major and 
minor), -143.41 (td, J = 15.7, 4.9 Hz, 2F, major and minor). 1H NMR (400 MHz, CDCl3) δ 5.10 
(t, J = 7.5 Hz, 1H), 3.96 (s, 3H), 3.45 (d, J = 7.5 Hz, 2H), 2.27 (t, J = 5.5 Hz, 2H), 2.11 – 2.00 (m, 
2H), 1.63 – 1.44 (m, 6H). 13C NMR (101 MHz, CDCl3) δ 160.2, 146.2 – 143.8 (ddd, J = 12.9, 6.4, 
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4.8 Hz), 145.8 – 143.4 (dt, J = 15.9, 4.6 Hz), 143.1, 123.9 (t, J = 18.7 Hz), 114.8, 109.7, 53.1, 
37.0, 29.7, 28.3, 26.7, 21.3. GC/MS (m/z, relative intensity) 316 (M+, 15), 285 (15), 235 (58). 
General procedure F was followed using methyl 
2,3,4,5,6-pentafluorobenzoate (14.8 μL, 0.1 mmol, 
1 equiv1,2,3,4,5-pentafluoro-6-((3-methyloct-1-
en-3-yl)oxy)benzene (142 μL, 0.6 mmol, 6 equiv), 
N,N-diisopropylethylamine (31.3 μL, 0.18 mmol, 
1.8 equiv), distilled water (18 μL, 1 mmol, 10 
equiv) and 1.0 mL of stock solution of Ir(ppy)3 (0.16 mg, 0.0003 mmol, 0.003 equiv) in CH3CN 
was used. The crude material was purified by using Prep TLC 10:1 hexane:diethyl ether to afford 
methyl (E)-2,3,5,6-tetrafluoro-4-(3-methyloct-2-en-1-yl)benzoate (5f) with E:Z 1.3:1 as a 
colorless liquid in 64% 19F NMR yield. Alkene geometry was assigned by NOE correlation of the 
allylic methylene to the cis substituent. 19F NMR (376 MHz, CDCl3) δ -140.23 – -140.41 (m, 4F, 
major and minor), -143.13 (tt, J = 15.1, 6.7 Hz, 4F, major and minor). 1H NMR (400 MHz, 
CDCl3) δ 5.15 (t, J = 7.3 Hz, 2H, major and minor), 3.96 (s, 6H, major and minor), 3.45 (d, J = 
7.3 Hz, 4H, major and minor), 2.22 – 2.09 (m, 2H, minor), 1.95 (d, J = 7.8 Hz, 2H), 1.73 (s, 3H), 
1.68 (s, 3H, minor), 1.45 – 1.14 (m, 12H, major and minor), 0.95 (t, J = 7.2 Hz, 3H, minor) – 0.83 
(t, J = 7.2 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 160.5, 146.2 – 143.6 (ddd, J = 12.9, 6.4, 4.8 
Hz), 145.8 – 143.1 (dt, J = 15.9, 4.6 Hz), 139.5, 139.3, 123.8 (t, J = 18.7 Hz), 118.4, 117.8, 110.3 
– 109.3 (m), 53.5 – 52.3 (m), 39.8 – 39.1 (m), 31.8 (d, J = 9.9 Hz), 31.4, 27.5, 22.5 (d, J = 9.3 
Hz), 22.2, 15.9, 14.0. GC/MS (m/z, relative intensity) 332 (M+, 18), 301 (22), 256 (30), 216 (68). 
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An NMR tube was charged with fluoroarene (0.1 mmol, 1.0 equiv), prenyl-OAr (0.6-0.8 mmol, 
6-8 equiv), N,N-diisopropylethylamine (0.18-0.4 mmol, 1.8-4 equiv), distilled water ( 1-1.5 
mmol, 10-15 equiv),  fac-tris(2- phenyl pyridinato-C2, N) Iridium(III) (Ir(ppy)3) (0.3 mM, 1 mL 
in MeCN), sealed glass capillary containing C6D6 and was capped with an NMR septum (Ace 
glass, part no. 9096-25). When reaction was run in greater than 0.1 mmol of fluoroarene, more 
than one NMR tube was used to set up the reaction and each NMR tube had 1 mL of reaction 
mixture. The reaction was degassed via Ar bubbling for 15 min at 0 °C (to avoid evaporation of 
N,N diisopropylethylamine and other volatile starting materials) and then placed in a light bath 
(vide supra) such that the lower portion of the tube was submerged under the isopropanol/water 
bath. 
The reaction was monitored periodically by 19F NMR (care was taken to exclude light while in 
transit). After the complete consumption of starting material, CH3CN was removed via rotavap. 
The crude material was purified using prep TLC plate. If the reaction did not go to completion 
with the first addition of N,N-diisopropylethylamine, an additional 1 - 3 equiv of N,N -
diisopropylethylamine was added to the reaction. Then the reaction was re-degassed and returned 




General procedure G was followed using methyl 2,3,4,5,6-pentafluorobenzoate 
(14.75 μL, 0.1 mmol, 1 equiv), 1,2,3,4,5-pentafluoro-6-((2-methylbut-3-en-2-
yl)oxy)benzene (117.3 μL, 0.6 mmol, 6 equiv), N,N-diisopropylethylamine (31.3 
μL, 0.18 mmol, 1.8 equiv), distilled water (18 μL, 1 mmol, 10 equiv) and 1.0 mL 
of stock solution of Ir(ppy)3 (0.16 mg, 0.0003 mmol, 0.003 equiv) in CH3CN was used. The crude 
material was purified by using Prep TLC 10:1 hexane:diethyl ether to afford methyl 2,3,5,6-
tetrafluoro-4-(3-methylbut-2-en-1-yl)benzoate (3a) as a colorless liquid in 68% 19F NMR yield 
and 61% isolated yield (16.6 mg, 0.06 mmol). 19F NMR (376 MHz, CDCl3) δ -140.23 – -140.38 
(m, 2F), -143.20 (dd, J = 21.4, 12.7 Hz, 2F). 1H NMR (400 MHz, CDCl3) δ 5.15 (t, J = 7.4 Hz, 
1H), 3.96 (s, 3H), 3.43 (d, J = 7.4 Hz, 2H), 1.74 (s, 3H), 1.69 (s, 3H). 13C NMR (101 MHz, 
CDCl3) δ 160.5, 146.1 – 143.6 (ddd, J = 12.9, 6.4, 4.8 Hz), 145.8 – 143.3 (dt, J = 15.9, 4.6 Hz), 
135.3, 123.6 (t, J = 18.8 Hz), 118.2, 110.0 (t, J = 15.7 Hz), 53.1, 25.6, 22.2, 17.6. GC/MS (m/z, 
relative intensity) 276 (M+, 20), 261 (35), 245 (15). This product was also obtained when 2-
fluoro-6-((2-methylbut-3-en-2-yl)oxy)pyridine was used as the prenyl source. However, in this 
case the reaction produced a significant side-product which we assume it to be methyl 2,3,5,6-
tetrafluoro-4-(3-methylbut-2-enoyl)benzoate (oxidized product) based on GC/MS (m/z, relative 
intensity) 290 (M+, 40) which is the mass of the side product. 
 
General procedure G was followed using isopropyl 2,3,4,5,6-
pentafluorobenzoate (16.6 μL, 0.1 mmol, 1 equiv), 1,2,3,4,5-pentafluoro-6-((2-
methylbut-3-en-2-yl)oxy)benzene (117.3 μL, 0.6 mmol, 6 equiv), N,N-
diisopropylethylamine (31.3 μL, 0.18 mmol, 1.8 equiv), distilled water (18 μL, 1 
mmol, 10 equiv) and 1.0 mL of stock solution of Ir(ppy)3 (0.16 mg, 0.0003 mmol, 0.003 equiv) in 
CH3CN was used. The crude material was purified by using Prep TLC 10:1 hexane:diethyl ether 
to afford isopropyl 2,3,5,6-tetrafluoro-4-(3-methylbut-2-en-1-yl)benzoate (3b) as a colorless 
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liquid in 65% 19F NMR yield and 58% isolated yield ( 18.24 mg, 0.06 mmol). 19F NMR (376 
MHz, CDCl3) δ -141.03 – -141.16 (m, 2F), -143.39 – -143.52 (m, 2F). 1H NMR (400 MHz, 
CDCl3) δ 5.34 – 5.25 (m, 1H), 5.15 (t, J = 7.3 Hz, 1H), 3.42 (d, J = 7.3 Hz, 2H), 1.74 (s, 3H), 
1.69 (s, 3H), 1.37 (d, J = 6.3 Hz, 6H). 13C NMR (101 MHz, CDCl3) δ 159.5, 145.9 – 143.6 (ddd, 
J = 12.9, 6.4, 4.8 Hz), 145.6 – 143.1 (dt, J = 15.9, 4.6 Hz), 135.2, 123.1 (t, J = 18.8 Hz), 118.4, 
111.0 (t, J = 16.3 Hz), 70.6, 25.6, 22.2, 21.7, 17.6. GC/MS (m/z, relative intensity) 304 (M+, 12), 
289 (7), 247 (22). 
General procedure G was followed using isobutyl 2,3,4,5,6-
pentafluorobenzoate (19.8 μL, 0.1 mmol, 1 equiv), 1,2,3,4,5-pentafluoro-6-((2-
methylbut-3-en-2-yl)oxy)benzene (117.3 μL, 0.6 mmol, 6 equiv), N,N-
diisopropylethylamine (31.3 μL, 0.18 mmol, 1.8 equiv), distilled water (18 μL, 1 
mmol, 10 equiv) and 1.0 mL of stock solution of Ir(ppy)3 (0.16 mg, 0.0003 mmol, 0.003 equiv) in 
CH3CN was used. The crude material was purified by using Prep TLC 10:1 hexane:diethyl ether 
to afford isobutyl 2,3,5,6-tetrafluoro-4-(3-methylbut-2-en-1-yl)benzoate (3c) as a colorless 
liquid in 66% 19F NMR yield and 60% isolated yield (19.08 mg, 0.06 mmol). 19F NMR (376 
MHz, CDCl3) δ -137.84 – -137.99 (m, minor), -141.06 – -141.21 (m, minor), -141.87 – -142.00 
(m), -143.61 – -143.73 (m). 1H NMR (400 MHz, CDCl3) δ 5.15 (t, J = 7.4 Hz, 1H), 3.41 (d, J = 
7.4 Hz, 2H), 1.74 (s, 3H), 1.69 (s, 3H), 1.59 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 158.9 (t, J = 
3.0 Hz), 145.8 – 143.4 (ddd, J = 13.0, 6.8, 4.5 Hz), 145.4 – 142.9 (dt, J = 15.9, 4.6 Hz), 135.0, 
122.5 (t, J = 18.8 Hz), 118.5, 112.1 (t, J = 16.8 Hz), 84.3, 28.1, 25.6, 22.1, 17.6. GC/MS (m/z, 
relative intensity) 318 (M+, 25), 262 (65), 247 (100). 
General procedure G was followed using 2,3,4,5,6-pentafluorobenzonitrile (12.9 
μL, 0.1 mmol, 1 equiv), 1,2,3,4,5-pentafluoro-6-((2-methylbut-3-en-2-
yl)oxy)benzene (117.3 μL, 0.6 mmol, 6 equiv), N,N-diisopropylethylamine (31.3 
μL, 0.18 mmol, 1.8 equiv), distilled water (18 μL, 1 mmol, 10 equiv) and 1.0 mL 
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of stock solution of Ir(ppy)3 (0.16 mg, 0.0003 mmol, 0.003 equiv) in CH3CN was used. The crude 
material was purified by using Prep TLC 10:1 hexane:diethyl ether to afford 2,3,5,6-tetrafluoro-
4-(3-methylbut-2-en-1-yl)benzonitrile (3d) as a colorless liquid in 71% 19F NMR yield and 64% 
isolated yield (14.58 mg, 0.06 mmol). 19F NMR (376 MHz, CDCl3) δ -133.13 – -133.26 (m, 2F), -
140.61 (td, J = 16.4, 6.9 Hz, 2F). 1H NMR (400 MHz, CDCl3) δ 5.13 (t, J = 7.2 Hz, 1H), 3.48 (d, 
J = 7.3 Hz, 2H), 1.75 (s, 3H), 1.71 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 148.3 – 145.7 (dt, J = 
14.3, 3.8 Hz), 145.9 – 143.4 (m), 136.3, 127.5 (t, J = 18.6 Hz), 117.3, 107.7 (t, J = 3.7 Hz), 29.7, 
25.7, 22.7, 17.7. GC/MS (m/z, relative intensity) 243 (M+, 34), 228 (40), 208 (18), 188 (35). 
General procedure G was followed using 1,2,3,4,5-pentafluoro-6-
(trifluoromethyl)benzene (14.16 μL, 0.1 mmol, 1 equiv), 1,2,3,4,5-pentafluoro-6-
((2-methylbut-3-en-2-yl)oxy)benzene (117.3 μL, 0.6 mmol, 6 equiv), N,N-
diisopropylethylamine (31.3 μL, 0.18 mmol, 1.8 equiv), distilled water (18 μL, 1 
mmol, 10 equiv) and 1.0 mL of stock solution of Ir(ppy)3 (0.16 mg, 0.0003 mmol, 0.003 equiv) in 
CH3CN was used. The crude material was purified by using Prep TLC 10:1 hexane:diethyl ether 
to afford 1,2,4,5-tetrafluoro-3-(3-methylbut-2-en-1-yl)-6-(trifluoromethyl)benzene (3e) as a 
colorless liquid in 61% 19F NMR yield and 57% isolated yield (16.3 mg, 0.057 mmol). 19F NMR 
(376 MHz, CDCl3) δ -56.20 (t, J = 21.5 Hz, 3F), -141.39 – -141.69 (m, 2F), -142.17 (td, J = 16.0, 
6.5 Hz, 2F). 1H NMR (400 MHz, CDCl3) δ 5.16 (t, J = 7.5 Hz, 1H), 3.46 (d, J = 7.4 Hz, 2H), 1.75 
(s, 3H), 1.71 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 146.2 – 143 (ddd, J = 17.1, 6.7, 4.0 Hz), 
145.4 – 142.5 (ddd, J = 12.6, 7.3, 3.3 Hz), 135.7, 129.0, 128.2, 125.3, 117.8, 25.7, 22.2, 17.7. 
GC/MS (m/z, relative intensity) 286 (M+, 52), 271 (64), 231 (34). 
General procedure G was followed using pentafluorobenzene (11.6 μL, 0.1 
mmol, 1 equiv), 2-fluoro-6-((2-methylbut-3-en-2-yl)oxy)pyridine (103 μL, 0.6 
mmol, 6 equiv), N,N-diisopropylethylamine (31.3 μL, 0.18 mmol, 1.8 equiv), 
distilled water (18 μL, 1 mmol, 10 equiv) and 1.0 mL of stock solution of Ir(ppy)3 
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(0.16 mg, 0.0003 mmol, 0.003 equiv) in CH3CN was used. The crude material was purified by 
using Prep TLC 1:1 hexane : DCM to afford 1,2,3,4,5-pentafluoro-6-(3-methylbut-2-en-1-
yl)benzene (3f) as a colorless liquid in 64% 19F NMR yield and 55% isolated yield (13.9 mg, 
0.06 mmol). Due to volatile nature of compound, minimal effort was given to remove the 
solvents. 19F NMR (376 MHz, CDCl3) δ -144.31 (dd, J = 22.3, 8.2 Hz, 2F), -158.81 (t, J = 20.7 
Hz, 1F), -163.29 (td, J = 22.3, 8.1 Hz, 2F). 1H NMR (400 MHz, CDCl3) δ 5.15 (t, J = 7.3 Hz, 
1H), 3.37 (d, J = 7.4 Hz, 2H), 1.74 (s, 3H), 1.69 (s, 3H). GC/MS (m/z, relative intensity) 236 
(M+, 70), 221 (85), 201 (20). The compound produced a thermally generated impurity under GC 
conditions that was otherwise not observed in 1H or 19F NMR. 
General procedure G was followed using pentafluoropyridine (10.9 μL, 0.1 
mmol, 1 equiv), 1,2,3,4,5-pentafluoro-6-((2-methylbut-3-en-2-yl)oxy)benzene 
(117.3 μL, 0.6 mmol, 6 equiv), N,N-diisopropylethylamine (31.3 μL, 0.18 mmol, 
1.8 equiv), distilled water (18 μL, 1 mmol, 10 equiv) and 1.0 mL of stock solution 
of Ir(ppy)3 (0.16 mg, 0.0003 mmol, 0.003 equiv) in CH3CN was used. The crude material was 
purified by using Prep TLC with 100% hexanes to afford 2,3,5,6-tetrafluoro-4-(3-methylbut-2-
en-1-yl)pyridine (3g) as a colorless liquid in 78% 19F NMR yield and 74% isolated yield (15.33 
mg, 0.07 mmol). Minimal effort was given to evaporate the solvent due to volatile nature of the 
product. 19F NMR (376 MHz, CDCl3) δ -91.72 – -91.93 (m, 2F), -145.20 – -145.42 (m, 2F). 1H 
NMR (400 MHz, CDCl3) δ 5.10 (t, J = 7.5 Hz, 1H), 3.42 (d, J = 7.5 Hz, 2H), 1.69 (s, 3H), 1.65 
(s, 3H). 13C NMR (101 MHz, CDCl3) δ 144.7 – 141.3 (m), 141.5 – 138.7 (m), 136.4, 134.3 (t, J = 
17.3 Hz), 116.9, 25.7, 22.9, 17.7. GC/MS (m/z, relative intensity) 219 (M+, 100), 204 (84), 184 
(62), 177 (40). 
General procedure G was followed using 3-chloro-2,4,5,6-
tetrafluoropyridine (12.44 μL, 0.1 mmol, 1 equiv), 1,2,3,4,5-pentafluoro-
6-((2-methylbut-3-en-2-yl)oxy)benzene (117.3 μL, 0.6 mmol, 6 equiv), 
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N,N-diisopropylethylamine (31.3 μL, 0.18 mmol, 1.8 equiv), distilled water (18 μL, 1 mmol, 10 
equiv) and 1.0 mL of stock solution of Ir(ppy)3 (0.16 mg, 0.0003 mmol, 0.003 equiv) in CH3CN 
was used. The crude material was purified by using Prep TLC with 100% hexanes to 2,3,4,6-
tetrafluoro-5-(3-methylbut-2-en-1-yl)pyridine (3i) as a colorless liquid in 57% 19F NMR yield 
and 41% isolated yield (8.97 mg, 0.04 mmol). Minimal effort was given to evaporate the solvent 
due to volatile nature of the product. 19F NMR (376 MHz, CDCl3) δ -73.43 – -73.64 (m, 1F), -
88.22 – -88.43 (m, 1F), -118.20 (q, J = 17.3 Hz, 1F), -167.39 (ddd, J = 24.1, 21.7, 19.6 Hz, 1F). 
1H NMR (400 MHz, CDCl3) δ 5.15 (t, J = 7.9 Hz, 1H), 3.32 (d, J = 7.2 Hz, 2H), 1.74 (s, 3H), 
1.70 (s, 3H). GC/MS (m/z, relative intensity) 219 (M+, 95), 204 (80), 184 (60). 
General procedure G was followed using 3,5-dichloro-2,4,6-
trifluoropyridine (12.44 μL, 0.1 mmol, 1 equiv), 1,2,3,4,5-pentafluoro-6-
((2-methylbut-3-en-2-yl)oxy)benzene (117.3 μL, 0.6 mmol, 6 equiv), 
N,N-diisopropylethylamine (31.3 μL, 0.18 mmol, 1.8 equiv), distilled water (18 μL, 1 mmol, 10 
equiv) and 1.0 mL of stock solution of Ir(ppy)3 (0.16 mg, 0.0003 mmol, 0.003 equiv) in CH3CN 
was used. The crude material was purified by using Prep TLC with 100% hexanes to afford 3-
chloro-2,4,6-trifluoro-5-(3-methylbut-2-en-1-yl)pyridine (3j) as a colorless liquid in 55% 19F 
NMR yield and 48% isolated yield (11.5 mg, 0.05 mmol). Minimal effort was given to evaporate 
the solvent due to volatile nature of the product. 19F NMR (376 MHz, CDCl3) δ -71.52 – -71.67 
(m, 1F), -72.44 (t, J = 13.6 Hz, 1F), -97.91 (dd, J = 19.5, 13.8 Hz, 1F). 1H NMR (400 MHz, 
CDCl3) δ 5.14 (t, J = 7.4 Hz, 1H), 3.32 (d, J = 7.4 Hz, 2H), 1.74 (s, 3H), 1.70 (s, 3H). 13C NMR 
(101 MHz, CDCl3) δ 167.4 – 164.8 (dd, J = 10.5, 4.9 Hz), 158.7 – 156.3 (m), 156.5 – 154.1 (m), 
135.2, 118.3, 115.4, 110.4 (ddd, J = 35.5, 20.0, 7.2 Hz), 25.6, 21.5, 17.7. GC/MS (m/z, relative 
intensity) 235 (M+, 50), 220 (100), 180 (70). 
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General procedure G was followed using 3,4-dichloro-
2,5,6-trifluoropyridine (12.4 μL, 0.1 mmol, 1 equiv), 
1,2,3,4,5-pentafluoro-6-((2-methylbut-3-en-2-
yl)oxy)benzene (117.3 μL, 0.6 mmol, 6 equiv), N,N-
diisopropylethylamine (31.3 μL, 0.18 mmol, 1.8 equiv), 
distilled water (18 μL, 1 mmol, 10 equiv) and 1.0 mL of stock solution of Ir(ppy)3 (0.16 mg, 
0.0003 mmol, 0.003 equiv) in CH3CN was used. The reaction was run at -15 oC instead of 0 oC to 
control the selectivity, delivering more para substituted product. The crude material was purified 
by using Prep TLC with 100% hexanes to afford 3-chloro-2,5,6-trifluoro-4-(3-methylbut-2-en-
1-yl)pyridine (major, 3k) as a colorless liquid in 81% 19F NMR yield and 73% isolated yield 
(16.51 mg, 0.06 mmol). It comprised of a mixture of para substituted product and meta prenylated 
product in the ratio 14.5:1 (para:meta). Looking at the 19F NMR of both isomers we see that these 
signals shift very closely to one another. Unfortunately, they shift too close to use recently 
developed 19F NMR prediction method (JOC, 2018, 83, 3220).  We unsuccessfully attempted to 
derivatize the mixture, which might have allowed us to distinguish the molecules so the 
assignment is unfortunately made based on analogy with 3l/3l’. In the substrate 3k, which has one 
fewer meta chlorines, we assume it follows the same pattern. Minimal effort was given to 
evaporate the solvent due to volatile nature of the product. 19F NMR (376 MHz, CDCl3) δ -73.85 
(dd, J = 26.9, 12.3 Hz, 1F, minor ), -74.15 (dd, J = 27.8, 12.8 Hz, 1F), -89.54 (dd, J = 20.9, 14.1 
Hz, 1F, minor), -89.91 (dd, J = 21.5, 12.8 Hz), -145.00 (dd, J = 25.7, 21.3 Hz, 1F, minor), -
145.33 (dd, J = 27.8, 21.7 Hz). 1H NMR (400 MHz, CDCl3) δ 5.15 (m, 2H, major and minor), 
3.58 (d, J = 7.2 Hz, 2H), 3.43 (d, J = 7.6 Hz, 2H, minor), 1.77 (s, 6H, major and minor), 1.70 (s, 
6H, major and minor). GC/MS (m/z, relative intensity) 235 (M+, 52), 220 (100), 180 (90). 
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General procedure G was followed using 3,4,5-
trichloro-2,6-difluoropyridine (12.44 μL, 0.1 mmol, 1 
equiv), 1,2,3,4,5-pentafluoro-6-((2-methylbut-3-en-2-
yl)oxy)benzene (117.3 μL, 0.6 mmol, 6 equiv), N,N-
diisopropylethylamine (31.3 μL, 0.18 mmol, 1.8 equiv), 
distilled water (18 μL, 1 mmol, 10 equiv) and 1.0 mL of stock solution of Ir(ppy)3 (0.16 mg, 
0.0003 mmol, 0.003 equiv) in CH3CN was used. The crude material was purified by using Prep 
TLC with 100% hexanes to afford 3,5-dichloro-2,6-difluoro-4-(3-methylbut-2-en-1-yl)pyridine 
(major, 3l) as a colorless liquid in 77% 19F NMR yield and 69% isolated yield (16.56 mg, 0.06 
mmol). It comprised of a mixture of para substituted product (single peak for symmetrical F-
atoms at -71.67 ppm) and meta prenylated product in the ratio 6:1 (para:meta), determined by 19F 
NMR Pdt1:Pdt2 peak integrations. 19F NMR (376 MHz, CDCl3) δ -70.67 (d, J = 16.4 Hz, 1F, 
minor), -71.67(s, 2F), -71.77 (d, J = 12.3 Hz, 1F, minor). 1H NMR (400 MHz, CDCl3) δ 5.07(m, 
1H), 4.99 (m, 1H, minor), 3.73 (d, J = 7.0 Hz, 2H), 3.49 (d, J = 7.1 Hz, 2H, minor), 1.84 (s, 3H), 
1.79 (s, 3H, minor), 1.74 (s, 3H), 1.72 (s, 3H, minor). GC/MS (m/z, relative intensity) 251 (M+, 
45), 216 (35), 200 (37). 
 
General procedure G was followed using 2-(perfluorophenyl)benzo[d]oxazole 
(18.6 μL, 0.1 mmol, 1 equiv), 1,2,3,4,5-pentafluoro-6-((2-methylbut-3-en-2-
yl)oxy)benzene (117.3 μL, 0.6 mmol, 6 equiv), N,N-diisopropylethylamine (31.3 
μL, 0.18 mmol, 1.8 equiv), distilled water (18 μL, 1 mmol, 10 equiv) and 1.0 mL 
of stock solution of Ir(ppy)3 (0.16 mg, 0.0003 mmol, 0.003 equiv) in CH3CN was 
used. The crude material was purified by using Prep TLC with 1% AcOH in hexanes to afford 2-
(2,3,5,6-tetrafluoro-4-(3-methylbut-2-en-1-yl)phenyl)benzo[d]oxazole (3m) as a pale yellow 
solid in 62% 19F NMR yield and 53% isolated yield (17.75 mg, 0.05 mmol), which includes 20% 
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HDF. 19F NMR (376 MHz, CDCl3) δ -137.11 – -137.33 (m, 2F, minor), -137.68 (tt, J = 16.9, 5.2 
Hz, 2F, minor), -138.79 – -138.93 (m, 2F), -143.04 (td, J = 15.1, 4.8 Hz, 2F). 1H NMR (400 
MHz, CDCl3) δ 7.89 (td, J = 7.7, 1.1 Hz, 1H), 7.65 (td, J = 7.8, 1.1 Hz 1H), 7.48 – 7.40 (m, 2H), 
5.22 (t, J = 7.4 Hz, 1H), 3.51 (d, J = 7.4 Hz, 2H), 1.78 (s, 3H), 1.73 (s, 3H). 13C NMR (101 MHz, 
CDCl3) δ 153.9 – 153.2 (m), 150.8 – 150.1 (m), 146.6 – 146.0 (m), 143.9 (dd, J = 21.2, 11.8 Hz), 
141.2, 135.4, 126.6, 126.3, 125.2, 125.0, 123.5, 118.2, 111.0, 25.7, 22.4, 17.7. GC/MS (m/z, 
relative intensity) 335 (M+, 100), 320 (80), 300 (42), 280 (70). 
General procedure G was followed using 2-(perfluorophenyl)-1H-
benzo[d]imidazole (28.4 mg, 0.1 mmol, 1 equiv), 1,2,3,4,5-pentafluoro-6-((2-
methylbut-3-en-2-yl)oxy)benzene (117.3 μL, 0.6 mmol, 6 equiv), N,N-
diisopropylethylamine (31.3 μL, 0.18 mmol, 1.8 equiv), distilled water (18 μL, 1 
mmol, 10 equiv) and 1.0 mL of stock solution of Ir(ppy)3 (0.16 mg, 0.0003 
mmol, 0.003 equiv) in CH3CN was used. Due to lower solubility of the 
perfluoroarene starting material, another 1 mL of dry CH3CN was added and the reaction mixture 
(0.05 M) was subjected to sonication after regular intervals. The crude material was purified by 
using Prep TLC with 100% hexanes followed by re-dipping the plate in 10:1 hexane:ether to 
afford 2-(2,3,5,6-tetrafluoro-4-(3-methylbut-2-en-1-yl)phenyl)-1H-benzo[d]imidazole (3n) as 
a pale yellow solid in 71% 19F NMR yield and 68% isolated yield (22.7 mg, 0.068 mmol),which 
includes 12% HDF. 19F NMR (376 MHz, CD3CN) δ -140.04 – -140.35 (m, 2F, minor), -141.66 – 
-141.84 (m, 2F, minor), -142.27 – -142.43 (m, 2F), -145.11 – -145.28 (m, 2F). 1H NMR (400 
MHz, CD3CN) δ 7.75 (dd, J = 6.1, 3.2 Hz, 2H), 7.38 (dd, J = 6.1, 3.2 Hz, 2H), 5.25 (t, J = 7.4 Hz, 
1H), 3.53 (d, J = 7.3 Hz, 2H), 1.79 (s, 3H), 1.72 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 146.9 
(m), 146.6 – 144.1 (ddt, J = 17.1, 12.7, 6.6 Hz), 145.7 – 143.2 (m), 140.3, 135.3, 124.0, 122.1 (t, 
J = 18.8 Hz), 118.3, 115.5 (dd, J = 33.9, 24.7 Hz), 107.0, 25.7, 22.3, 17.7. GC/MS (m/z, relative 




General procedure G was followed using 2-(perfluorophenyl)benzo[d]thiazole 
(31.76 mg, 0.1 mmol, 1 equiv), 1,2,3,4,5-pentafluoro-6-((2-methylbut-3-en-2-
yl)oxy)benzene (117.3 μL, 0.6 mmol, 6 equiv), N,N-diisopropylethylamine (31.3 
μL, 0.18 mmol, 1.8 equiv), distilled water (18 μL, 1 mmol, 10 equiv) and 1.0 mL 
of stock solution of Ir(ppy)3 (0.16 mg, 0.0003 mmol, 0.003 equiv) in CH3CN was 
used. The crude material was purified by using Prep TLC with 100% hexanes 
followed by re-dipping the plate in 10:1 hexane:ether to afford 2-(2,3,5,6-tetrafluoro-4-(3-
methylbut-2-en-1-yl)phenyl)benzo[d]thiazole (3o) as a white solid in 68% 19F NMR yield and 
62% isolated yield (21.76 mg, 0.06 mmol). 19F NMR (376 MHz, CDCl3) δ -140.17 – -140.29 (m, 
2F), -143.38 – -143.51 (m, 2F). 1H NMR (400 MHz, CDCl3) δ 8.20 (d, J = 8.1 Hz, 1H), 7.98 (d, J 
= 8.0 Hz, 1H), 7.57 (td, J = 7.6, 1.2 Hz 1H), 7.48 (td, J = 7.7, 1.1 Hz, 1H), 5.23 (t, J = 7.4 Hz, 
1H), 3.50 (d, J = 7.4 Hz, 2H), 1.78 (s, 3H), 1.72 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 154.1, 
152.9, 146.6 – 144.1 (ddd, J = 13.0, 6.8, 4.5 Hz), 145.4 – 142.9 (dt, J = 15.9, 4.6 Hz), 135.6 (t, J 
= 2.5 Hz), 135.2, 126.6, 126.1, 125.2, 124.1, 122.3 (t, J = 18.9 Hz), 121.4, 118.5, 25.7, 22.3, 17.7. 





















































































General procedure H for photocatalytic geranylation reaction 
An NMR tube was charged with fluoroarene (0.1 mmol, 1.0 equiv), 1-((3,7-dimethylocta-1,6-
dien-3-yl)oxy)-2,3,4,5,6-pentafluorobenzene (0.6 mmol, 6 equiv), N,N-diisopropylethylamine 
(0.18 mmol, 1.8 equiv), distilled water (1 mmol, 10 equiv), fac-tris(2- phenyl pyridinato-C2, N) 
Iridium(III) (Ir(ppy)3) (0.3 mM, 1 mL in MeCN), sealed glass capillary containing C6D6 and was 
capped with an NMR septum (Ace glass, part no. 9096-25). When reaction was run in greater 
than 0.1 mmol of fluoroarene, more than one NMR tube was used to set up the reaction and each 
NMR tube had 1 mL of reaction mixture. The reaction was degassed via Ar bubbling for 15 min 
at 0 °C (to avoid evaporation of N,N-diisopropylethylamine and other volatile starting materials) 
and then placed in a light bath (vide supra) such that the lower portion of the tube was submerged 
under the isopropanol/water bath. 
The reaction was monitored periodically by 19F NMR (care was taken to exclude light while in 
transit). After the complete consumption of starting material, CH3CN was removed via rotavap. 
The crude material was purified using prep TLC plate. If the reaction did not go to completion 
with the first addition of N,N-diisopropylethylamine, an additional 1-3 equiv of N,N -
diisopropylethylamine was added to the reaction. Then the reaction was re-degassed and returned 





General procedure H was followed using 
methyl 2,3,4,5,6-pentafluorobenzoate 
(14.75 μL, 0.1 mmol, 1 equiv), 1-((3,7-
dimethylocta-1,6-dien-3-yl)oxy)-2,3,4,5,6-
pentafluorobenzene (147 μL, 0.6 mmol, 6 
equiv), N,N-diisopropylethylamine (31.3 μL, 0.18 mmol, 1.8 equiv), distilled water (18 μL, 1 
mmol, 10 equiv) and 1.0 mL of stock solution of Ir(ppy)3 (0.16 mg, 0.0003 mmol, 0.003 equiv) in 
CH3CN was used. The crude material was purified by using Prep TLC 10:1 hexane:diethyl ether 
to afford methyl (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4,5,6-tetrafluorobenzoate (7a) and 
methyl (E)-4-(3,7-dimethylocta-2,6-dien-1-yl)-2,3,5,6-tetrafluorobenzoate (7a’) as a colorless 
liquid in 42% and 27% 19F NMR yield respectively (o-Ger : p-Ger = 1.55:1). This was 
determined using 19F NMR peak integrations (four –F peaks as a result of  ortho-substitution and 
two peaks arising from para-substitution. 19F NMR (376 MHz, CDCl3) δ -134.34 – -134.51 (m, 
1F), -138.07 (dd, J = 22.8, 12.4 Hz, 1F), -140.14 (ddd, J = 21.6, 12.4, 5.2 Hz, 1F), -140.21 – -
140.38 (m, 2F, minor), -140.44 (ddd, J = 21.8, 12.4, 5.2 Hz, 1F), -142.99 – -143.15 (m, 2F, 
minor). 1H NMR (400 MHz, CDCl3) δ 5.44 (t, J = 7.0 Hz, 1H), 5.16 (t, J = 14.6 Hz, 2H, major 
and minor), 5.03 (t, J = 7.5 Hz, 1H, minor), 3.97 (s, 3H), 3.96 (s, 3H, minor), 3.45 (d, J = 7.3 Hz, 
2H), 3.19 (d, J = 10.7 Hz, 2H, minor), 2.34 – 1.96 (m, 8H, major and minor), 1.77 (d, J = 1.5 Hz, 
3H), 1.74 (s, 3H, minor), 1.70 (s, 3H), 1.69 (s, 3H, minor), 1.64 (s, 3H), 1.63 (s, 3H, minor).13C 
NMR (101 MHz, CDCl3) δ 160.5, 160.2, 147.1 – 145.4 (m), 146.4 – 143.5 (m), 145.9 – 143.6 
(m), 145.5 – 142.8 (m), 140.2, 138.8 (d, J = 13.0 Hz), 132.1, 131.7, 127.4 (t, J = 17.2 Hz), 123.9, 
123.7, 121.8, 118.7, 118.3, 110.1 (t, J = 15.7 Hz), 53.1, 49.2, 41.8, 39.5, 37.2, 34.3, 31.8, 30.4, 
26.4, 26.3, 26.1, 25.7, 25.6, 25.2, 22.2, 17.6, 16.1. GC/MS (m/z, relative intensity) 344 (M+, 15), 





General procedure H was followed using 
isopropyl 2,3,4,5,6-pentafluorobenzoate 
(16.7 μL, 0.1 mmol, 1 equiv), 1-((3,7-
dimethylocta-1,6-dien-3-yl)oxy)-2,3,4,5,6-
pentafluorobenzene (147 μL, 0.6 mmol, 6 
equiv), N,N-diisopropylethylamine (31.3 μL, 0.18 mmol, 1.8 equiv), distilled water (18 μL, 1 
mmol, 10 equiv) and 1.0 mL of stock solution of Ir(ppy)3 (0.16 mg, 0.0003 mmol, 0.003 equiv) in 
CH3CN was used. The crude material was purified by using Prep TLC 10:1 hexane:diethyl ether 
to afford isopropyl (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4,5,6-tetrafluorobenzoate (7b) 
and isopropyl (E)-4-(3,7-dimethylocta-2,6-dien-1-yl)-2,3,5,6- tetrafluorobenzoate (7b’) as a 
colorless liquid in 42% and 26% 19F NMR yield respectively (o-Ger : p-Ger = 1.6:1). This was 
determined using 19F NMR peak integrations (assignment was made based on the analogy with 
7a). 19F NMR (376 MHz, CDCl3) δ -134.55 – -134.77 (m, 1F), -138.32 (dd, J = 22.8, 12.4 Hz, 
1F), -140.82 – -140.97 (m, 1F), -140.99 – -141.17 (m, 2F, minor), -141.17 – -141.27 (m, 1F), -
143.22 – -143.44 (m, 2F, minor). 1H NMR (400 MHz, CDCl3) δ 5.44 (t, J = 7.0 Hz, 2H), 5.30 
(hept, 2H, major and minor), 5.15 (t, J = 9.2 Hz, 2H, major and minor), 5.05 – 5.00 (m, 1H, 
minor), 3.44 (d, J = 7.3 Hz, 3H), 3.18 (d, J = 10.7 Hz, 3H, minor), 2.33 – 2.01 (m, 8H, major and 
minor), 1.76 (s, 3H), 1.73 (s, 3H, minor), 1.70 (d, J = 2.3 Hz, 3H, minor), 1.65 (s, 3H), 1.63 (d, 
3H, minor), 1.57 (s, 3H), 1.39 (d, 3H), 1.38 (d, 3H, minor), 1.37 (d, 3H), 1.36 (d, 3H, minor). 13C 
NMR (101 MHz, CDCl3) δ 159.5, 159.2, 147.9 – 146.4 (m), 147.2 – 145.8 (m), 147.1 – 143.0 
(m), 144.8 – 142.6 (m), 140.2, 138.8, 138.7, 132.1, 131.7, 127.0, 126.6, 123.8, 123.7, 123.1, 
121.9, 119.8, 118.9, 118.3, 111.3 – 110.8 (m), 70.7, 70.6, 53.4, 49.2, 41.9, 39.5, 37.2, 34.3, 30.4, 
26.3 (d, J = 9.9 Hz), 26.1 (d, J = 6.7 Hz), 25.7 (d, J = 8.6 Hz), 25.3, 22.1 (d, J = 5.9 Hz), 21.7, 




General procedure H was followed using 
Pentafluorobenzonitrile (12.6 μL, 0.1 
mmol, 1 equiv), 1-((3,7-dimethylocta-1,6-
dien-3-yl)oxy)-2,3,4,5,6-
pentafluorobenzene (147 μL, 0.6 mmol, 6 
equiv), N,N-diisopropylethylamine 
(31.3 μL, 0.18 mmol, 1.8 equiv), distilled water (18 μL, 1 mmol, 10 equiv) and 1.0 mL of stock 
solution of Ir(ppy)3 (0.16 mg, 0.0003 mmol, 0.003 equiv) in CH3CN was used. The crude material 
was purified by using Prep TLC 10:1 hexane:diethyl ether to afford (E)-2-(3,7-dimethylocta-2,6-
dien-1-yl)-3,4,5,6-tetrafluorobenzonitrile (7c) and (E)-4-(3,7-dimethylocta-2,6-dien-1-yl)-
2,3,5,6-tetrafluorobenzonitrile (7c’) as a colorless liquid in 45% and 27% 19F NMR yield 
respectively (o-Ger : p-Ger = 1.65:1). This was determined using 19F NMR peak integrations 
(four –F peaks as a result of  ortho-substitution and two peaks arising from para-substitution). 
Assignment was made based on the analogy with 7a. 19F NMR (376 MHz, CDCl3) δ -132.13 (ddt, 
J = 16.9, 11.2, 5.6 Hz, 1F), -133.01 (ddd, J = 20.6, 12.1, 7.4 Hz, 1F), -133.22 (tt, J = 16.6, 8.4 Hz, 
2F, minor), -133.47 (ddd, J = 22.0, 12.0, 7.3 Hz, 1F), -135.40 (dd, J = 22.1, 12.1 Hz, 1F), -140.50 
(tt, J = 16.5, 8.5 Hz, 2F, minor). 1H NMR (400 MHz, CDCl3) δ 5.44 (t, J = 7.0 Hz, 2H, major and 
minor), 5.13 (t, J = 7.4 Hz, 1H), 5.01 (t, J = 7.5 Hz, 1H, minor), 3.49 (d, J = 1.8 Hz, 2H), 3.23 (d, 
2H, minor), 2.36 – 1.92 (m, 8H, major and minor), 1.77 (s, 3H), 1.74 (s, 3H, minor), 1.69 (s, 3H), 
1.64 (s, 3H, minor), 1.62 (s, 3H, minor), 1.57 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 148.1 (d, J 
= 6.4 Hz), 147.9 (d, J = 6.6 Hz), 148.8 – 146.2 (m), 148.1 – 145.8 (m), 144.6 (dt, J = 15.9, 4.6 
Hz), 143.8 – 142.6 (dt, J = 15.9, 4.6 Hz), 140.1, 139.8, 132.2, 131.8, 131.1, 127.7, 127.5, 123.6, 
121.7, 117.1, 107.7, 91.8, 49.5, 39.5, 37.4, 34.2, 30.2, 26.2, 25.9 (d, J = 6.8 Hz), 25.7, 25.2, 23.2, 
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22.6, 22.2 (d, J = 6.2 Hz), 17.6 (d, J = 2.9 Hz), 16.1. GC/MS (m/z, relative intensity) 311 (M+, 
15), 296 (5), 268 (35), 255 (10). 
General procedure H was followed using 
Pentafluoropyridine (10.9 μL, 0.1 mmol, 1 
equiv), 1-((3,7-dimethylocta-1,6-dien-3-
yl)oxy)-2,3,4,5,6-pentafluorobenzene (147 
μL, 0.6 mmol, 6 equiv), N,N-diisopropylethylamine (31.3 μL, 0.18 mmol, 1.8 equiv), distilled 
water (18 μL, 1 mmol, 10 equiv) and 1.0 mL of stock solution of Ir(ppy)3 (0.16 mg, 0.0003 
mmol, 0.003 equiv) in CH3CN was used. The crude material was purified by using Prep TLC 
10:1 hexane:diethyl ether to afford (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4,5,6-
tetrafluoropyridine (7d) and (E)-4-(3,7-dimethylocta-2,6-dien-1-yl)-2,3,5,6-
tetrafluoropyridine (7d’) as a colorless liquid in 43% and 26% 19F NMR yield respectively (o-
Ger : p-Ger = 1.67:1). Assignment was made based on the analogy with 7a. 19F NMR (376 MHz, 
CDCl3) δ -91.62 – -92.13 (m, 3F, major and minor), -92.39 (ddd, J = 28.6, 21.8, 14.0 Hz, 1F), -
136.75 – -136.99 (m, 1F), -140.61 – -140.98 (m, 1F), -145.00 – -145.32 (m, 2F, minor). 1H NMR 
(400 MHz, CDCl3) δ 5.48 – 5.39 (m, 1H), 5.22 – 5.14 (m, 1H), 5.14 – 5.08 (m, 1H, minor), 5.02 
(dt, J = 6.8, 4.1 Hz, 1H, minor), 3.50 (d, J = 7.4 Hz, 2H), 3.23 (d, J = 10.9 Hz, 2H, minor), 2.38 – 
1.96 (m, 8H, major and minor), 1.77 (s, 3H), 1.75 (s, 3H, minor), 1.69 (s, 3H), 1.64 (s, 3H, 
minor), 1.62 (s, 3H), 1.57 (s, 3H, minor). 13C NMR (101 MHz, CDCl3) δ 149.5 – 148.9 (m), 
148.6 – 147.9 (m), 147.6 – 147.1 (m), 146.9 – 146.2 (m), 145.7 – 142.7 (m), 144.9 – 142.1 (m), 
140.2, 139.9, 139.8, 139.1 (d, J = 9.0 Hz), 131.8, 123.6, 123.5, 121.7, 117.5, 116.8, 49.7, 41.8, 
39.5, 37.1, 34.1, 26.3, 25.7 – 25.4 (m), 25.2, 22.9 – 22.7 (m), 22.6, 22.1 (d, J = 6.0 Hz), 17.6, 




General procedure I for the attempted photocatalytic farnesylation reaction 
 
 
An NMR tube was charged with fluoroarene (0.1 mmol, 1.0 equiv), 1-((3,7-dimethylocta-1,6-
dien-3-yl)oxy)-2,3,4,5,6-pentafluorobenzene (0.6 mmol, 6 equiv), N,N-diisopropylethylamine 
(0.18 mmol, 1.8 equiv), distilled water (1 mmol, 10 equiv), fac-tris(2- phenyl pyridinato-C2, N) 
Iridium(III) (Ir(ppy)3) (0.3 mM, 1 mL in MeCN), sealed glass capillary containing C6D6 and was 
capped with an NMR septum (Ace glass, part no. 9096-25). When reaction was run in greater 
than 0.1 mmol of fluoroarene, more than one NMR tube was used to set up the reaction and each 
NMR tube had 1 mL of reaction mixture. The reaction was degassed via Ar bubbling for 15 min 
at 0 °C (to avoid evaporation of N,N diisopropylethylamine and other volatile starting materials) 
and then placed in a light bath (vide supra) such that the lower portion of the tube was submerged 
under the isopropanol/water bath. 
The reaction was monitored periodically by 19F NMR (care was taken to exclude light while in 
transit). After the complete consumption of starting material, CH3CN was removed via rotavap. 
The crude material was purified using prep TLC plate. If the reaction did not go to completion 
with the first addition of N,N-diisopropylethylamine, an additional 1 - 3 equiv of N,N -
diisopropylethylamine was added to the reaction. Then the reaction was re-degassed and returned 
to the light bath. This sequence was repeated until the reaction reached completion as judged by 
19F NMR. 
General procedure I was followed using methyl 2,3,4,5,6-pentafluorobenzoate (14.7 μL, 0.1 
mmol, 1 equiv), (E)-1,2,3,4,5-pentafluoro-6-((3,7,11-trimethyldodeca-1,6,10-trien-3-
yl)oxy)benzene (154 μL, 0.6 mmol, 6 equiv), N,Ndiisopropylethylamine (31.3 μL, 0.18 mmol, 1.8 
equiv), distilled water (18 μL, 1 mmol, 10 equiv) and 1.0 mL of stock solution of Ir(ppy)3 (0.16 
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mg, 0.0003 mmol, 0.003 equiv) in CH3CN was used. The reaction produced 7 products 
(determined by GC/MS). An attempt was made to improve the selectivity by lowering the 
temperature to -20 oC and/or varying the amount of farnesyl ether in the reaction but these 
multiple products were still observed at those conditions. 
Table 1.15: Optimization of attempted farnesylation reaction at -20 oC 
 
Table 1.16:  Change in product ratios on varying conditions  
(Determined by calculating peak areas in GC/MS) 
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One interesting feature of this project was the observed change in regioselectivity of the major 
product upon moving from prenylation to geranylation. This is the first report of preferential 
ortho fragmentation based on reagent (we have shown that an intramolecular hydrogen bond can 
cause the ortho fragmentation to occur preferentially). Thus, we approached this with a healthy 
skepticism.  We based the proposed structure on the basis of several arguments which are 
outlined below. First, we observed 6 peaks in the 19F NMR which could arise from 3 para-
substituted products in which 2 of them were produced in the same ratio, or alternatively the 
reaction produces two products in total, i.e., expected para-geranylated product that accounts for 
two 1:1 –F signals and an ortho-geranylated product which accounts for four –F signals in a 
1:1:1:1 relationship with one another. We ruled out the possibility of formation of 3 para-
substituted products as the four –F signals were found to be present in the same spin system as 
confirmed by 19F-19F TOCSY. Another major evidence that supported ortho-geranylation was that 
upon running a AgNO3 impregnated silica column chromatography in an attempt to separate the 
C–C coupled products from one another, we observed that the compound eluted in such a way 
that each and every fraction (from very early to late fractions) produced four 1:1:1:1 peaks in 19F 
NMR, suggesting either perfect co-elution of two compounds or that this was a single compound. 
Other evidences included appropriate and distinct vinyl protons, methyl ester, methylene and 
methyl peaks in 1H NMR, two separate peaks of same m/z determined by GCMS, genuine 4-bond 
F–F couplings observed in 19F-19F COSY47. Another very important study to validate ortho C-C 
coupled product was to calculate predicted 19F NMR shifts for ortho-geranylated product. We 
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observed that the actual 19F NMR shifts fell in the acceptable range of error.48 Apart from that, we 
determined that all the F-atoms were attached to distinct C-atoms by 19F-13C HSQC and 1H-13C 
HSQC further confirmed our assignment of vinyl, methyl ester, benzylic methylene, methylene 
from geranyl chain and methyl protons on 1H NMR. Alkene geometry was assigned by NOE 
correlations.  
1. 19F NMR  
Observation:  
 Four distinct 1:1:1:1 peaks with similar splitting pattern supported o-Geranylated 
pdt (-134.4, -138.2, -140, -140.4) 
 Two 1:1 peaks confirmed p-Geranylated pdt (-140.3 and -143.1) 
2. 1H NMR 
 4 vinyl protons (5.01-5.5 ppm) 
 Methylene (3.2-3.4 ppm and 1.95-2.35 ppm) and methyl peaks (1.55-2.78 ppm) 
from both compounds 
3. GC/MS 
 2 peaks each of M+ 344 (at 17.4 and 17.6 mins retention time) 
4. Isolation using AgNO3 impregnated silica column  
 19F NMR of various fractions contained either 1:1:1:1 peaks for o-Geranylated 
product or 1:1 peaks for p-Geranylated product  
5. 19F-19F TOCSY 
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 4 –F peaks in the same spin-system  
 2 –F peaks within another spin-system 
6. 19F-19F COSY  
 4-bond coupling stronger than 3-bond coupling 
 F-1 and F-3 showed strong correlation 
 F-2 showed strong correlation with F-4  
 Weak interaction observed between F-1 and F-4 
7. Structure prediction using NMR calculations 
 




8. 19F – 13C HSQC 
 The four –F peaks are attached to four different C-atoms 
9. 1H-13C HSQC 
 A total of 4 vinyl protons from both molecules  5.0-5.5 ppm 
 2 separate methyl ester peaks (3.94-4.0 ppm) 
 2 benzylic methylene signals (3.2 and 3.4 ppm) 
 Presence of 4 types of alkyl methylene signals (1.95-2.35 ppm)  
[This region includes peaks from minor side-products] 
 Both products produces a total of 6 different methyl signals in the alkyl region 

























In order to gain a better insight on the interactions between substrates, we carried out UV-Vis 
experiments. We did not see any interaction between perfluoroarene and prenylating source, but 

































NMR Titration experiments: 
Several combinations of 19F NMR titrations were also carried out that in turn demonstrated no 
significant interactions between perfluoroarene and prenylating agent at ground state. 













Evidence for no post-reaction isomerization in geranylated products: 
Table 1.17: Evidence for no post-reaction isomerization in geranylated products: 
 
In order to check for post-reaction isomerization of geranylated products, while we were not able 
to completely resolve these isomers, we were able to collect samples enriched in one or the other 
isomers after chromatography by taking early and late fractions.  When we re-subjected the 
enriched mixtures to a number of conditions (see above), we saw that the ratio never 
















Figure 1.10: ortho-Ger enriched mixture 
1. para-Ger enriched mixture  
83 
 





4.   
5.  
Figure 1.11: para-Ger enriched mixture 
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13C NMR (101 MHz, CDCl3, at rt) spectrum of methyl (E)-2,3,5,6-tetrafluoro-4-(3-methyloct-





























































































































































































































1H NMR (400 MHz, CDCl3, at rt) spectrum of 1,2,3,4,5-pentafluoro-6-(3-methylbut-2-en-1-
yl)benzene (3f) 











































































































































































1H NMR (400 MHz, CDCl3, at rt) spectrum of 3,5-dichloro-2,6-difluoro-4-(3-methylbut-2-en-
1-yl)pyridine (3l)  
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19F NMR (376 MHz, CDCl3, at rt) spectrum of 2-(2,3,5,6-tetrafluoro-4-(3-methylbut-2-en-1-
yl)phenyl)benzo[d]oxazole (3m)  
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1H NMR (400 MHz, CDCl3, at rt) spectrum of 2-(2,3,5,6-tetrafluoro-4-(3-methylbut-2-en-1-








13C NMR (101 MHz, CDCl3, at rt) spectrum of 2-(2,3,5,6-tetrafluoro-4-(3-methylbut-2-en-1-



























19F NMR (376 MHz, CDCl3, at rt) spectrum of 2-(2,3,5,6-tetrafluoro-4-(3-methylbut-2-en-1-
yl)phenyl)-1H-benzo[d]imidazole (3n)  
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13C NMR (101 MHz, CDCl3, at rt) spectrum of 2-(2,3,5,6-tetrafluoro-4-(3-methylbut-2-en-1-























19F NMR (376 MHz, CDCl3, at rt) spectrum of 2-(2,3,5,6-tetrafluoro-4-(3-methylbut-2-en-1-
yl)phenyl)benzo[d]thiazole (3o)  
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1H NMR (400 MHz, CDCl3, at rt) spectrum of 2-(2,3,5,6-tetrafluoro-4-(3-methylbut-2-en-1-



























19F NMR (376 MHz, CDCl3, at rt) spectrum of methyl (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-




1H NMR (376 MHz, CDCl3, at rt) spectrum of methyl (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-
3,4,5,6-tetrafluorobenzoate (7a) and methyl (E)-4-(3,7-dimethylocta-2,6-dien-1-yl)-2,3,5,6-





























13C NMR (376 MHz, CDCl3, at rt) spectrum of methyl (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-

































19F -19F TOCSY of methyl (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4,5,6-tetrafluorobenzoate 




19F -19F COSY of methyl (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4,5,6-tetrafluorobenzoate 




19F-13C HSQC of methyl (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4,5,6-tetrafluorobenzoate 




1H-13C HSQC of methyl (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4,5,6-tetrafluorobenzoate 




1H-1H NOESY of methyl (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4,5,6-tetrafluorobenzoate 
(7a) and methyl (E)-4-(3,7-dimethylocta-2,6-dien-1-yl)-2,3,5,6-tetrafluorobenzoate (7a’)  
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GC and MS of methyl (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4,5,6-tetrafluorobenzoate (7a) 










19F NMR (376 MHz, CDCl3, at rt) spectrum of isopropyl (E)-2-(3,7-dimethylocta-2,6-dien-1-




1H NMR (376 MHz, CDCl3, at rt) spectrum of isopropyl (E)-2-(3,7-dimethylocta-2,6-dien-1-

























13C NMR (376 MHz, CDCl3, at rt) spectrum of isopropyl (E)-2-(3,7-dimethylocta-2,6-dien-1-

























GC and MS of isopropyl (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4,5,6-tetrafluorobenzoate 










19F NMR (376 MHz, CDCl3, at rt) spectrum of (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4,5,6-




















1H NMR (376 MHz, CDCl3, at rt) spectrum of (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4,5,6-

























13C NMR (376 MHz, CDCl3, at rt) spectrum of (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4,5,6-






































19F NMR (376 MHz, CDCl3, at rt) spectrum of (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4,5,6-




1H NMR (376 MHz, CDCl3, at rt) spectrum of (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4,5,6-






























13C NMR (376 MHz, CDCl3, at rt) spectrum of (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4,5,6-

























GC and MS of (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4,5,6-tetrafluorobenzonitrile (7d) and 
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